Irradiation mucositis and oral flora. Reduction of mucositis by selective elimination of oral flora by Spijkervet, Frederik Karst Lucien
  
 University of Groningen
Irradiation mucositis and oral flora. Reduction of mucositis by selective elimination of oral flora
Spijkervet, Frederik Karst Lucien
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
1989
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Spijkervet, F. K. L. (1989). Irradiation mucositis and oral flora. Reduction of mucositis by selective
elimination of oral flora. [s.n.].
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019

IRRADIATION MUCOSITIS AND ORAL FLORA 
Reduction of mucositis by selective elimination of oral flora 
CIP-GEGEVENS KONINKLIJKE BIBLIOTHEEK, DEN HAAG 
Spijkervet, Frederik Karst Lucien 
Irradiation mucositis and oral flora : reduction of mucositis by selective elimination of oral 
flora/ Frederik Karst Lucien Spijkervet ; [ill. J. Duitsch ... et al.]. - [S.l. : s.n.]. - Ill. 
Proefschrift Groningen. - Met lit. opg. - Met samenvatting in het Nederlands. 
ISBN 90-367-0117-1 
SISO 605.13 UDC 616.31 (043.3) NlJGI 742 
Trefw.: mucositis / orale flora. 
STELLINGEN 
behorende bij het proefschrift 
Irradiation mucositis and oral flora 
reduction of mucositis by selective elimination of oral flora 
I 
Gram-negative bacilli are causative in the development of irradiation mucositis. 
II 
Chlorhexidine mouth rinses are obsolete in oropharyngeal decontamination procedures. 
III 
Special combinations of circumstances of a fortuitous nature are necessary before coloniza­
tion, invasion and carrierstate of foreign micro-organisms can occur. 
AL. Bloomfield in Amer Rev Tuberc 1922;5:903-914. 
IV 
Oral Gram-negative bacillary carriage is not only a symptom of underlying disease but it 
also constitutes a genuine illness on its own. 
V 
No relation exists between oral yeast colonization and any of the mucositis signs. 
VI 
Surveillance cultures of the oral flora are indispensable in a proper patientcare during head 
and neck irradiation therapy. 
VII 
De toestemming voor het dragen van het kunstgebit tijdens hoofd-halsbestraling is een 
kunstfout en leidt tot kunstmatige voeding. 
VIII 
Objective scoring methods in medicine are always subjective. 
IX 
Antibiotica dienen eigenlijk uitsluitend als prophylaxe te worden voorgeschreven. 
X 
The conclusion that the substantial toxicity of radiotherapy delivered to the oral cavity 
constitutes an intrinsic property of these tissues, is not justified. 
XI 
De klassificatie van fibro-osseuze-cementeuze dysplasie van de kaken is eenvoudig. 
XII 
De methode 'twee vliegen in een klap' is van toepassing op de hoofdoverwegingen in het 
'Strucmur-rapport kaakchirurgie tot het jaar 2000'. Het ongedaan maken van de reductie 
van medische basis- en klinische vakken in het curriculum van de studie tandheelkunde is 
in vele opzichten effectiever en zinvoller dan de toelatingseis van de 'dubbele kwalificatie'. 
XIII 
Het recht der volksvertegenwoordiging van de parlementaire enquete moet de verantwoor­
delijke bewindslieden inzake de M-fregatten der Koninklijke Marine doen besluiten open 
kaart te spelen; een dergelijke enquete lijkt anders onafwendbaar. 
XIV 
De hoogte van de kortingspercentages op de prijzen van kinderspeelgoed suggereert op zijn 
minst een winst die ontoelaatbaar is. 
Groningen, 8 februari I 989 F.K.L. Spijkervet 
'--------------------------'ll 
RIJKSUNIVERSITEIT GRONINGEN 
IRRADIATION MUCOSITIS AND ORAL FLORA 
Reduction of mucositis by selective elimination of oral flora 
PROEFSCHRIFT 
ter verkrijging van het doctoraat in de 
Geneeskunde 
aan de Rijksuniversiteit Groningen 
op gezag van de 
Rector Magnificus Dr. L.J. Engels 
in het openbaar te verdedigen op 
woensdag 8 februari 1989 
des namiddags te 2.45 uur precies 
door 
Frederik Karst Lucien Spijkervet 
geboren te Meppel 
Promotores 
Referent 
Prof. Dr. A.K. Panders 
Prof. Dr. A. Vermey 
Dr. H.K.F. van Saene, senior lecturer 
Promotie-commissie: Prof. Dr. G. Boering 
Paranimfen 
Dr. M.V. Martin, senior lecturer 
Prof. Dr. J. Vermeij 
Ors. C.P. van Steenis 
Drs. P. Wilms 
I have had several gentle women in my house, who were keen on seeing the little eels in vinegar; 
but some of 'em were so disgusted at the spectacle, that they vowed they'd ne'er use vinegar 
again. But what if one should tell such people in future that there are more animals living in the 
scum on the teeth in a man's mouth, than there are men in a whole kingdom? 
Anthonie van Leeuwenhoek 
voor mijn ouders 
voor Willy en Karin 
This study was supported by the Netherlands Cancer Foundation (KWF), 
grant no. GUKC 86-3. 
Deze studie is gesubsidieerd door het Koningin Wilhelmina Fonds (KWF), 
projectnr. GUKC 86-3. 
6 
Contents 
Chapter 1 Introduction 9 
I Mucositis by irradiation 9 
2 Oral flora 11 
3 Aims of lhe study 13 
4 Design of lhe study 13 
Chapter 2 Scoring irradiation mucositis in head and neck cancer patients 19 
Chapter 3 Colonization index of lhe oral cavity: a novel technique for monitoring 
colonization defence 31 
Chapter 4 Effect of chlorhexidine rinsing on the oropharyngeal ecology in patients 
wilh head and neck cancer who have irradiation mucositis 41 
Chapter 5 Chlorhexidine inactivation by saliva 51 
Chapter 6 Chlorhexidine rinsing fails in reducing irradiation mucositis in head and 
neck cancer patients 61 
Chapter 7 : Effect of selective elimination of the oral flora on the oropharyngeal ecology 
in patients wilh head and neck cancer during conventional irradiation 
protocol. A pilot study 73 
Chapter 8 
Chapter 9 
Inactivation of polymyxin E and tobramycin by saliva 85 
Mucositis prevention by selective elimination of oral flora in irradiated head 
and neck cancer patients. A pilot study 95 
Chapter 10 : General discussion 105 
1 Significance of the study 105 
2 Hypothesis 109 
3 Suggestions for further lines of research 109 









1 MUCOSITIS BY IRRADIATION 
1.1 Definition 
Mucositis induced by irradiation is defined as the reactive inflammatory-like process of the 
oropharyngeal mucous membrane following therapeutic irradiation of patients who have head 
and neck cancer. Irradiation mucositis is an inevitable but transient side effect.1•2 
1. 2 Magnitude of the clinical problem 
Although mucositis is a transient complication, it is an integral part of the radiation therapy in 
terms of morbidity.3 The response of normal tissues, e.g. oral mucosa, is often a dose-limiting 
factor in therapeutic radiation. Irradiation mucositis can have a notable impact on the individual. 
Pain, difficulties in drinking, eating and swallowing can limit food intake.4 Other mucositis 
related complications are sleeping problems, speaking difficulties and progressive deterioration 
in the well-being of the patient. The generalized complaints that result from mucositis may 
necessitate changes in the radiation treatment planning. 
1.3 Clinical course of mucositis 
Clinically different local signs of mucositis may emerge during radiotherapy. The first clinical 
signs of mucositis occur at the end of the first week of a six week conventional radiation 
protocol5•6 (daily dose of 2 Gy, five times a week). However, there is no consensus about what 
is the first sign of clinical mucositis. Some authors describe a white mucosa! appearance which 
is an expression of a higher degree of hyperkeratinization as the first mucositis symptom7•8 
followed or in combination with erythema. Others consider that the first reaction is erythema, 
due to vascular dilatation (hyperaemia)9•10 or obstructive changes in arterioles.1 1 More severe 
symptoms of mucositis are described as the formation of pseudomembranes (mucous plaque 
formation, patchy or confluent mucositis) and ulcerations, which will appear after about three 
weeks of irradiation.9,10 
The exact reason for the formation of pseudomembranes remains unclear. Rosenthal & 
Wilkie have described the dose dependency.12 Some consider that pseudomembranes are due 
to yeast stomatitis,8 however, this has not been confirmed microbiologically. Others have 
suggested that pseudomembranes are ulcers covered by fibrinous exudate although this has not 
been proven histologically.6•9 
1.4 Histopathology of mucositis 
The clinical manifestations of radiation damage occur when cell numbers are depleted to some 
critical value.13·15 Experimental mice have been used to investigate histologically the radiobio­
logical effects of irradiation on mucosa. Defects are produced because cells are not renewed 
from the basal epithelial layer after maturation and exfoliation.16 
The development and severity of side effects of radiation in normal tissue, depend on tissue 
9 
Table I: Normal oral flora composition. 
(after: Rosebury Th, 1962; Rosenthal S & Tager IB, 1975; 
















































related factors e.g. sensitivity of cellular compartments, and irradiation related factors such as 
total irradiation dose, volume of irradiated tissue, fractionation and type of ionizing radiation.1•11 
Hence, the early radiobiological responses to therapeutic radiation in head and neck cancer 
patients are especially seen in rapid renewing tissues, such as the oral mucosa. 7•17•18 
1.5 Techniques for mucositis scoring 
To be able to record the degree and extent of mucositis due to irradiation treatment in head and 
neck cancer patients is important both from a clinical and a research point of view. Scoring 
mucositis is necessary for proper communication among clinicians about the severity of 
mucositis and related generalized complaints,19•20 as well as for studying the dose-response 
relation21 and for research purposes to evaluate preventive or therapeutic measures.22 
Several methods have been described for quantifying oral mucositis. 19•21•23-26 All but Van der 
Schueren ct al. record local mucositis symptoms together with generalized complaints.21 The 
scoring method as described by Van der Schueren is the only one which looks purely at 
mucositis, and disregards the general symptoms or complaints. The dose-response relationship 
has been shown by this method. However, the weak spot in this scoring technique is the 
inadequate definition of the differences between the various local signs, e.g. between 'slight' 
and 'pronounced' erythema. The other mucositis scoring techniques include generalized side 
effects. In all these publications a level or degree describes a local sign of mucositis and/or 
generalized problems that result from mucositis. None of these methods are quantitative, i.e. the 
extent of the local signs are not quantified. 
20RALFLORA 
2.1 Composition 
The bacteria colonizing the oral cavity in healthy subjects consists of a myriad of large numbers 
of anaerobes as well as aerobic micro-organisms (table I). The colonizing anaerobes include e.g. 
Actinomyces, Bacteroides, Fusobacterium and Veillonella species. Aerobic colonizing micro­
organisms are e.g. viridans streptococci, Neisseria species, enterococci and Micrococcus 
species. 21-32 Oral micro-organisms may be classified in three major categories depending on the 
intrinsic pathogenicity:33 (1) 'indigenous' micro-organisms are carried by everybody and are 
highly concentrated (�1()6 colony forming units per ml of saliva). These bacteria live in a 
symbiotic relationship with the host and they have a low pathogenic potential, e.g. viridans 
streptococci. (2) 'community' acquired micro-organisms are carried by varying percentages of 
healthy people, are low concentrated and are potentially pathogenic, e.g. yeasts. About 50% of 
healthy individuals carry Streptococcus pneumoniae, Haemophilus influenzae and Bran­
hamella catarrhalis,28whereas 20-40% carry Staphylococcus aureus34 and yeast species in the 
oropharynx. 35.36 (3) 'hospital' acquired micro-organisms are uncommon in healthy people. Less 
than 10% of healthy people are colonized in the oral cavity with Enterobacteriaceae, Pseudo­
monadaceae and Acinetobacter species,37 and if colonized, the concentration of bacteria per ml 
of saliva is low (< 103 colony forming units per ml of saliva).38 The group of the 'hospital' 
acquired Gram-negative bacilli belongs to the category of potentially pathogenic micro­
organisms. The potential of causing oral infections is low, e.g. Klebsiella species. 
2.2 Colonization defence of the oral cavity 
Bloomfield (1922) was the first to describe protective mechanisms that delete foreign micro­
organisms in healthy persons and prevent colonization. 39 Healthy people are able to cope with 
huge challenges of bacteria which are supplied daily by food and beverages.40 
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Major factors contributing to oropharyngeal colonization defence are (1) integrity of the 
anatomical structures,41 (2) physiology,42 (3) motility,43 (4) secretions,44 (5) secretory immuno­
globulin A,45 (6) mucosal cell turnover46 and (7) the indigenous oral flora.47 Conditions that 
deplete one or more of the seven factors that contribute to colonization defence of the oral cavity 
may impair the clearance of Gram-negative bacilli and yeasts. 
Local changes promoting decrease of colonization defence are: (1) changes of the oral 
mucous membrane as a result from e.g. chemotherapy;48 (2) altered quality of saliva by 
cytostatics;49 (3) impaired swallowing in ventilated patients;50 ( 4) decreased flow of saliva in e.g. 
Sjogrens syndrome;51 (5) diminished amount of lgA promoting colonization of potentially 
pathogenic Gram-negative bacilli;52 (6) changes in mucosal cell turnover, which is associated 
with enhanced adherence and colonization;53 and (7) changes of the normal flora due to 
antimicrobial therapy, promoting colonization of potentially pathogenic micro-organisms.54 
More generalized factors related to colonization of Gram-negative bacilli in the oral cavity are 
advanced age,55 medical interventions such as surgery56 and underlying disease.57 
2.3 The influence of irradiation on oral defence against colonization in patients who have head 
and neck cancer 
The (seven) factors that contribute to the defence of the oral cavity against colonization are all 
impaired by irradiation: 
1. anatomical lesions, e.g. increased permeability;14 
2. physiological changes, e.g. specific changes in the salivary protein composition;58 
3. impaired motility, e.g. impaired swallowing;22 
4. reduced salivary secretion, e.g. a reduction of more than 90% after a total dose of 40 Gy;59 
5. changes in secretory immunoglobulin A (s-lgA), e.g. the depressed total saliva lgA levels 
may diminish the antimicrobial activity of saliva;60 
6. altered mucosal cell turnover, e.g. decreased mitotic activity in the basal layer; 13 
7. alterations in the indigenous flora, e.g. increase in lactobacilli.61•62 
An individual who has head and neck cancer and who receives therapeutic irradiation should be 
considered to be a patient at high risk of oral colonization with Gram-negative bacilli, because 
all seven factors aimed at clearance are impaired by irradiation procedures. Several different 
groups have reported oral Gram-negative bacillary carriage in the irradiated patient who has 
head and neck cancer.20•22•61•61-66 
2. 4 Techniques for culturing oral flora 
A true picture of the normal oral flora, and the effects of therapeutic measures on oral flora, can 
be assessed only by making repeated cultures from the same individual.67 Moreover, multiple 
quantitative cultures are needed to investigate carriage and colonization index. For the culture 
of oral flora, numerous techniques are available: the swab,68 saliva culture,69 the oral rinse 
method,70 or saline gargle method71 and the imprint technique.72 
Johnston and Bodey showed in their study that a gargle or oral rinse method is superior to 
several other methods for the following reasons.71 Firstly, gargling permits sampling from the 
entire oropharyngeal cavity, even from otherwise inaccessible areas. Secondly, a gargle method 
allows a minimal sampling variation by using a defined gargle volume and a specified gargling 
time. Samaranayake et al. confirmed these observations in reporting that a concentrated oral 
rinse method was as sensitive as the imprint culture technique of the tongue.73 
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2.5 Oral flora suppression 
Oral flora suppression can be obtained directly by the use of topical antimicrobial agents or 
indirectly by systemic antibiotics excreted in saliva. Elimination of S.aureus from the oro­
pharynx using high doses of systemic orally administered cephradine (100 mg/kg/day) has been 
reported by Van Saene et al.74 Topical application of disinfecting agents and antibiotics have also 
been used for oral flora suppression: e.g. chlorhexidine,75-78 hexetidine,79 penicillin G,80 
aminoglycosides,80-82 tetracyclines,83 nitrofuran,84 erythromycin,85 vancomycin,86-88 poly­
myxins89 and metronidazole.90 Different modes of application were by rinses, gels, pastilles, 
lozenges, chewing gums, dentifrices, chewing troches, or by tooth powder. 
Oral flora suppression techniques are used for reduction of plaque, prevention of postextrac­
tion bacteremia,91 prevention and treatment of gingivitis, alveolitis {dry socket) and yeast 
stomatitis. Oral flora suppression is an integral part of infection prevention policies in severely 
compromised patients: neutropenic,81 bone marrow transplant92 and intensive care patients.93-95 
Oral flora suppression has already been used in the irradiated head and neck cancer patients, but 
only disinfecting agents i.e. chlorhexidine have been studied.66•96 
3 AIMS OF THE STUDY 
The substantial morbidity of local signs of mucositis and generalized symptoms that result from 
mucositis induced by therapeutic irradiation prompted us to initiate a study with following 
objectives: 
1. Is it possible to prevent irradiation mucositis via oral flora elimination? 
2. If it is true that flora plays a (partial) role in irradiation mucositis, what fraction of the oral 
flora may be involved? 
3. To evaluate oral Gram-negative bacillary carriage. 
4. Is it possible to eradicate Gram-negative bacilli from the oral cavity? 
5. To evaluate oral yeast carriage. 
6. Is it possible to eradicate yeasts from the oral cavity? 
7. To determine the pathogenesis of yeast stomatitits. 
8. To determine the 'selectivity' of elimination of oral flora. 
4 DESIGN OF THE STUDY 
To monitor alterations of mucositis of the oral cavity and changes in oral flora, qualitative and 
quantitative techniques need to be used. These two methods are described in chapters 2 and 3. 
Chlorhexidine is tested as the commonly used prophylaxis. The effect of chlorhexidine 0.1 % 
rinses on oral flora and mucositis is studied in a prospective placebo controlled double blind 
randomized programme (chapters 4 and 6). The results of the influence of saliva on the 
antimicrobial activity of chlorhexidine are reported in chapter 5. The results of selective 
elimination of oral flora in irradiated patients who have head and neck cancer are reported in 
chapters 7 and 9. The design for this arm of the study is consecutive. Salivary inactivation of the 
topical antimicrobials used for selective elimination of oral flora is studied and the results are 
reported in chapter 8. Chapter 10 is the key chapter of the thesis. After a brief preamble to 
reiterate the aims of the study, the objectives that have been achieved ( or are not achieved) are 
delineated. The significance of the results of the study are discussed in terms of published 
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Figure 1: White discoloration of the buccal mucosa of the left cheek. 
Figure 2: Erythema of the buccal mucosa of the right cheek. 
Figure 3: Pseudomembranes of the buccal mucosa of the right cheelc 
ancl soft palate. 
ABS1RACT 
Irradiation mucositis is defined as an inflammatory-like process of the oropharyngeal mucosa 
following therapeutic irradiation of patients who have head and neck cancer. Clinically it is a 
serious side effect because severe mucositis can cause generalized problems (weight loss, 
nasogastric tube feedings) and interferes with the well-being of the patient seriously. Grading 
mucositis is important for the evaluation of preventive and therapeutic measures. The objective 
of this study was to develop a scoring method based on local mucositis signs only. Four clinical 
local signs of mucositis were used in this score: white discoloration, erythema, pseudomembra­
nes and ulceration. Mucositis of the oral cavity was calculated during conventional irradiation 
protocol for eight distinguishable areas using the four signs and their extent A prospective 
evaluation of this method in fifteen irradiated head and neck cancer patients displayed a S-curve 
reflecting a symptomless first irradiation week, followed by a rapid and steady increase of white 
discoloration, erythema and pseudomembranes during the second and third week. Yeast 
stomatitis, generalized symptoms such as weight loss and the highest mucositis scores were seen 
after three weeks of irradiation. The novel mucositis scoring method may be of value in studying 
the effect of hygiene programmes, topical application of disinfectans or antibiotics on oral 
mucositis. 
IN1RODUCTION 
Oral mucositis induced by irradiation is defined as a reactive inflammatory-like process of the 
oropharyngeal mucous membranes.1-3The first signs of inflammatory changes in the mucos are 
clinically seen at the end of the first week of a conventional irradiation protocol. Sometimes it 
is seen as a white discoloration but mostly as a reddening ( erythema) of the mucosa. During the 
irradiation therapy the more severe stages of mucositis may develop, such as the fonnation of 
pseudomembranes (3 to 4 weeks) and ulcerations. The severity of mucositis is detennined by 
radiation modalities as dose per day, cumulative dose, volume of irradiated tissue and type of 
ionizing irradiation.4.S Mucositis is an inevitable but transient side-effect of radiotherapy and 
causes serious complaints such as pain, swallowing-, eating- and speech problems. Further­
more, mucositis may affect not only the patient but can also interfere with his well-being to such 
a degree that this is a reason for alterations in the radiation treatment planning. 
Grading oral mucositis is crucial to document the degree of this side effect, 6 to evaluate the 
dose-response relationship7 and to investigate results of preventive treatment.8 There are reports 
available on grading mucositis following different irradiation plans, during intravenous hyper­
alimentation9 and oral hygiene programmes. 10,1 1  All these grading systems, however, are based 
on two or more different clinical parameters such as redness, pain and feeding problems. 
Therefore, we initiated the development of a novel scoring method based on the local mucositis 
signs only, measuring in a qualitative and quantitative way. This technique is illustrated by 
scoring mucositis in fifteen irradiated head and neck cancer patients and the results are compared 
with those of three other scoring systems described in the literature. 
MATERIALS and METHODS 
Scoring mucositis. Mucositis was evaluated using qualitative and quantitative parameters. Four 
different local signs of mucositis might be distinguished: 1 = white discoloration, the white 
appearance of oral mucosa (figure 1); 2 = erythema, defined as redness more pronounced than 
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the red colour of non-irradiated normal mucosa (figure 2); 3 = formation of pseudomembranes, 
i.e. white or yellow mucous plaques which are difficult to detach (figure 3); 4 = ulceration, 
defined as the local complete loss of the mucosa! layer. Mucositis of the oral cavity was 
determined for maximally eight (n = 8) distinguishable irradiated areas of the mouth: buccal 
mucosa (left & right), soft and hard palate, dorsum and border of the tongue (left & right) and 
the mouth floor. The borders of these areas are defined by Roed-Petersen.12 An area (the i-th 
area; i = 1 ,  ... n) might include several subareas dependent on the different local signs of mucositis 
observed in that particular area. The degree of mucositis for each subarea was scored by the value 
k on an ordinal scale (table 1). In one particular area there might be several subareas with an 
identical local sign of m ucositis. The length of each subarea was measured by a modified pocket 
gauge (figure 4), which was handy to use in the oral cavity, more particular in the more 
inaccessible areas, e.g. the mouth floor. The lengths of all subareas of identical local sign in one 
particular area were summed. The lenght (sum of lenghts) of subareas corresponded with a value 
E on an ordinal scale (table 1). The degree of mucositis of a subarea was defined as the product 
of the values k and E. 
Figure 4. 
The modified pocket gauge with interchangeable gauges of 2 and 4 cm. 
Them ucositis score of an area was defined as the sum of these products. Finally, the mucositis 
score a was defined as the mean of the scores assigned to n irradiated areas; the formula of the 
mucositis score a is as follows: 
n 4 





Table 1: The indices for the local rnucositis signs and the indices for the length of the rnucositis signs as 
used in the rnucositis score a. 
Local sign k Length E 
No rnucositis 0 
White discoloration 1 :;; 1 cm 1 
Erytherna 2 1 -2 cm 2 
Pseudornernbranes 3 2-4 cm 3 
Ulceration 4 > 4  cm 4 
Example: a patient with all distinguishable areas in the field of radiation has erythema of the 
mucosa on both cheeks with a length greater than 4 cm. Further two pseudomembranes of 1.5 cm 
and I cm are obvious at the right border of the tongue. The mucositis score for this patient is 
calculated as: 
erythema left buccal mucosa 
erythema right buccal mucosa 
pseudomembranes border tongue 
(2•4) + (2•4) + (3•3) 25 
= 2; length > 4 cm = 4 
= 2; length > 4 cm = 4 
= 3; length 2.5 cm 
(1.5 + 1 cm) = 3 
a = ------- = -- = 3. 1  
8 8 
The mucositis score a is a combination of ordinal scale assessments. The choice of the scores 
is subjective, inevitably. For example, the impact of the difference between the values k of2 and 
I respectively (corresponding with local sign erythema and white discoloration), on the score 
is similar to the impact of the difference between values k of 4 and 3 (corresponding with 
ulceration and pseudomembranes). Despite the arbitrariness involved one might expect that a 
higher score a corresponded with a clinically more severe condition. 
Evaluation of validity and reproducibility of mucositis score a. The validity of the mucositis 
score a was evaluated by comparing a with different commonly used methods of mucositis 
scoring. The mucositis score a was compared with three other methods described in the 
Ii terature:6•7 •9 
1. The WHO-index6 has the following grading: grade 0: no change; grade 1: soreness/ 
erythema; grade 2: erythema/ulcers/can eat solids; grade 3: ulcers/requires liquid diet only; 
grade 4: alimentation not possible. 
2. The method used by Hickey9 grades mucositis as follows: grade 0: no stomatitis; grade 1 :  
whitish gingival area or patient mentions slight burning sensation or discomfort in oral 
cavity; grade 2: moderate erythema and ulcerations or white patches present; patient 
complains of pain, but can eat, drink, and swallow; grade 3: severe erythema and ulcerations 
or white patches present; patient complains of severe pain and cannot eat, drink, or swallow. 
3. The scoring system proposed by Van der Schueren:7 level 0: no changes; level 1: slight 
erythema; level 2: pronounced erythema; level 3: spotted mucositis; level 4: confluent 
mucositis, patches larger than 5 mm. 
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The four techniques of scoring mucositis mentioned were applied in all patients in the study three 
times a week (Monday, Wednesday, Friday) during the five weeks of conventional irradiation 
protocol. Patients did not enter the study at the same day of the week. In order to represent weekly 
results of each patient the available observations were averaged. 
In order to evaluate the reproducibility of the mucositis score a pairs of measurements were 
compared. The measurements were recorded on two different days in the fourth week of the 
irradiation protocol. The differences between the successive measurements overestimate the 
amount of intra-observer error, but under the present design it was not possible to obtain 
independent repeated assessments of the same clinical situation. 
Yeast stomatitis. This is defined as an acute infection of the mucous membranes of the oral 
cavity. The most common symptoms of yeast stomatitis are burning sensation, tenderness and 
dryness. Clinically yeast stomatitis may present itself as superficial strand-like or drop-like 
growths that become confluent and form pearly-white elevated patches that resemble milk 
curds; or as a deep red erosion of the oral mucosa and patchy depapillation of the dorsum of the 
tongue, with minimal evidence of white lesions.13 Yeast stomatitis is mostly associated with 
;:;>: 105 colony forming units of yeast cells per ml of saliva.14 
Evaluation of generalized side effects. Local mucositis signs may be that severe that the 
patient may suffer pain in chewing, swallowing, speech and eating. These complaints may 
interfere with the feeding of the patient. Weight loss is an objective criterium and reflects best 
a real feeding problem. 15 The only criterium for generalized side effects used in this study was 
weight loss, leading to the need of nasogastric tube feedings, defined as a J, •ss of more than 1 kg 
per week. 
Patients. Fifteen patients with malignancies of the upper aero-digestive tract participated in 
the study. Informed consent was received from all patients. All patients received bilateral 
external irradiation (Co� via parallel opposed portals, 2 Gy daily, five times a week and a total 
dose of at least 50 Gy midline dose. The irradiation portals were comparable in all patients and 
included the major salivary glands. Surgical treatment of the tumor preceded the course of 
radiotherapy in twelve out of fifteen patients. All patients received before starting th\! irradiation 
protocol dental examination and treatment if necessary (e.g. restoration of gross decay, 
smoothing of sharp restorations or cusps, elimination of periapical or periodontal infections). 
Edentulous patients were not allowed to wear their prostheses during the irradiation course, 
while dentate patients applied a neutral fluoride gel with custom-made trays daily. 
All patients received a strict oral hygiene programme during the radiation period. The oral 
cavity was sprayed daily by an oral hygienist. The spray solution was sterile demineralized 
flavoured water. The oral hygienist carefully cleansed all mouth areas in this way. The patients 
also rinsed their mouths with this solution for 1 minute, three times a day. The amount of fluid 
sprayed and rinsed was about 100 ml per day (spraying 50 ml, rinsing 50 ml). 
RESULTS 
Fifteen patients (mean age 54.1  years, range 33-87) were studied prospectively (table 2). 
Thirteen patients wereedentulous and two weredentate. The measurement of mucositis with our 
scoring system as used in this study took about five minutes per patient including observing, 
filling out a preprinted form and calculating the score. 
Table 3 a, b and c show the clinical data of the patients during the 5 weeks of irradiation 
protocol. Erythema occurred for an average of 8.6 days (s.d. 2.1), with a mucositis score a of 2.0 
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Table 2: Patient data. 
patient age sex type neoplasm* surgery irrad. dose (Gy) 
1 43 f sec yes 50 
2 44 m ac yes 66 
3 66 m sec yes 66 
4 87 f sec yes 66 
5 65 m sec yes 66 
6 65 f sec no 66 
7 33 f ac yes 66 
8 60 m sec yes 66 
9 43 m sec yes 66 
10 55 f nhl no 50 
1 1  65 m sec yes 66 
12 40 m sec yes 66 
13 48 m nhl no 50 
14 56 m sec yes 68 
15 42 m sec yes 66 
mean f : m  yes : no 
54.1 1 :  3 12 : 3 
* sec = squamous cell carcinoma 
ac = adenocarcinoma 
nhl = non-Hodgkin lymphoma 
(s.d. 0.8) and at a dose of 12 Gy (range 8-18 Gy). Twelve patients (80%) developed 
pseudomembranes mainly on day 18.8 (s.d. 5.3) with a mucositis score a of 5.6 (s.d. 1.7) and 
at a dose of 26.7 Gy (range 16-44 Gy) during the radiation protocol. Ulcerations were not 
observed in any patient. The highest mucositis score achieved was 9 .3 (s.d. 1 .4) on average day 
28 (s.d. 5.3), at a dose of 38.5 Gy (s.d. 7 .5). Two patients developed yeast stomatitis on day 22 
(a 9.7; 30 Gy) and day 36 (a 8.7; 50 Gy). Five patients needed nasogastric tube feedings after 
(average) 25 days (range 19-33 days). Their mucositis score was minimally 10 at the time of 
onset of artificial feeding. 
Three phases may be distinguished observing the a mucositis curve (figure 5 d) during the 
period of five weeks of irradiation protocol. (1) Irradiation did not induce mucositis signs during 
the first week. (2) Mucositis signs developed during the second and third week: white 
discoloration and/or erythema appeared at day 8, while the most severe stage of pseudomem­
branes was reached at the end of the third week (day 18.8). The steepness of the slope reflects 
the quick and steady a increase associated with the aggravation of the local signs during week 
two and three. (3) A plateau was established after day 21 (30 Gy): the highest mucositis score 
mainly as a result from expansion and spreading of mucositis was achieved during weeks four 
and five. 
This S-curve was obtained by all four mucositis scoring techniques (figure 5 a, b, c, d). 
Although generalized symptoms were included in the WHO- and Hickey-method, the ultimate 
slope was determined by local mucositis signs only. 
Figure 6 depicts the results of the intra-observer agreement for the mucositis score a. The 
variation in recording was minimal. 
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Table 3 a: First sign of mucositis in the study patients. 
patient sign time (day) dosis (Gy) a 
1 White discolor. 7 10 0.3 
2 Erythema 1 1  12 1 .7 
3 White discolor. 9 14 0.4 
4 Erythema 6 8 2.6 
5 Erythema 12 18 1.1 
6 Erythema 7 10 1 .3 
7 Erythema 7 10 2.3 
8 Erythema 7 10 1 .1  
9 Erythema 10 16 3.9 
10 Erythema 10 16 1.3 
1 1  Erythema 13 16 3.2 
12 Erythema 8 10 2.0 
13 Erythema 8 10 1 . 1  
14 Erythema 7 10 2.3 
15 Erythema 7 10 1 .7 
Mean 8.6 12.0 1.8 
s.d. 2.1 3.0 1.0 
Table 3 b: Most severe mucositis sign in the study patients. 
patient sign time (day) dosis (Gy) a 
1 Pseudomembranes 16 22 2.6 
2 Pseudomcmbranes 20 26 6.3 
3 Pseudomembranes 16 24 5.6 
4 Pscudomembranes 17 24 8.3 
5 Pseudomembranes 33 44 7.3 
6 Erythema 7 10 1 .3 
7 Pseudomcmbranes 16 24 5.0 
8 Pseudomembranes 21 30 8.3 
9 Pseudomembranes 17 26 6.1 
10 Pseudomembranes 24 36 4.0 
1 1  Erythema 13 16 3.2 
12 Erythema 8 10 2.0 
13 Pscudomcmbranes 19 28 4.2 
14 Pscudomembranes 14 20 3.9 
15 Pseudomembrancs 12 16 5.6 
Mean 16.9 23.7 4.9 
s.d. 6.2 8.7 2.1 
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Table 3 c: Highest mucositis score and generalized symptoms observed in the study patients. 
patient sign time (day) dosis (Gy) a Symptoms 
1 Pseudomembranes 33 44 1 1 .5 Alimentation problems/weight loss 
(tube feeding day 33/44 Gy) 
2 Pseudomembranes 22 30 9.7 Candida stomatitis day 22/30 Gy 
Alimentation problems/weight loss 
(tube feeding day 20/26 Gy) 
3 Pseudomembranes 21 30 9.0 
4 Pseudomembranes 30 38 10.4 Alimentation problems/weight loss 
(tube feeding day 33/44 Gy) 
5 Pseudomembranes 33 44 7.3 
6 Erythema 23 28 8.0 
7 Pseudomembranes 19 26 9.7 Alimentation problems/weight loss 
(tube feeding day 20/28 Gy) 
8 Pseudomembranes 30 44 10.3 
9 Pseudomembranes 22 32 10.1 Candida stomatitis (day 36/50 Gy) 
10 Pseudomembranes 3 1  46 7.0 
1 1  Erythema 24 34 9.6 
12 Erythema 37 50 10.0 
13 Pseudomembranes 26 38 6.4 
14 Pseudomembranes 33 46 8.9 Severe xerostomia 
15 Pseudomembranes 33 46 1 1 .0 Alimentation problems/weight loss 
(tube feeding day 19/26 Gy) 
Mean 28.0 38.5 9.3 
s.d. 5.3 7.5 1 .4 
DISCUSSION 
The major aim of this prospective study was the evaluation of am  ucositis scoring method based 
solely on local mucositis signs in fifteen patients irradiated for head and neck cancer using an 
intensive thrice weekly assessment over five weeks of irradiation therapy. A second objective 
was to compare this technique with three other methods described up to now. The pattern of the 
mucositis course is practically identical for the four scoring methods during the first three weeks 
of irradiation course. This observation may be explained by the fact that irradiation in this period 
induces mainly local mucositis effects. Day 21 (30 Gy) apparently constitutes a crucial 
breakpoint, because after three weeks generalized symptoms occurred such as feeding problems 
and yeast stomatitis as well as the highest mucositis score ex. 
The mucositis scores developed by Van der Schueren and our group arc basically research 
techniques to evaluate dose-response relationships and the effects of prcventi ve measures on 
mucositis, respectively. These aims needed careful recording of local mucositis signs. The 
mucositis score ex developed in this study is more precious than the Van der Schueren-score. We 
used four distinguishable signs monitored in a quantitative way, while Van der Schueren defines 
two major signs split up into slight and pronounced erythema (qualitative distinction) and 
spotted and confluent mucositis (quantitative difference). 
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Figure 6: 
This figure shows the intra-observer agreement with respect to the mucositis score a. The mucositis scores 
of the first and second measurement during the fourth week of irradiation for all patients are plotted. 
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always reflect the clinical condition of the patient. It was found that all patients needing 
nasogastric tube feedings had a mucositis score a of minimally 10, but not all patients with an 
a score of 10 experienced that severe feeding problem. E.g. an irradiated patient who have only 
erythema at all eight areas already scores 8. The WHO- and Hickey-method are to be preferred 
for clinical use only. The mucositis score a would be applicable for patients where only the 
oropharynx is treated, whereas the other three methods could be used also to score mucositis in 
the hypopharynx and eventually the larynx. 
Intrigueing observations from this study are: 
I. A steep slope during weeks two and three, associated with a steady and quick development 
of local mucositis signs, i.e. white discoloration, erythema and pseudomembranes. 
2. Day 21 (30 Gy) is found to be a crucial time associated with the onset of yeast stomatitis, 
generalized symptoms and the highest mucositis score. 
The first observation is in accordance with that noted by at least one other previous study in 
which the phase of erythema is dose related.16 AI-Tikriti et al. reported that "After cessation of 
treatment the erythema resolved and four to six months after treatment was not detectable. ( ... ) 
it is probable that the sign is directly attributable to the radiation".8 From this point of view it 
is very unlikely that the signs responsible for the steep slope are to be preventable or avoidable. 
Baker17 described that the radiobiological basis for oral tissue reactions following therapeutic 
irradiation is basically a tissue reaction characterized by inflammation and necrosis. In addition 
to this cytotoxic action of radiation, the dose fractions used in therapeutic programmes increase 
tissue permeability.18•20 This increased permeability would occur after three weeks and 30 Gy. 
There are reports suggesting that the oropharyngeal flora may contribute to irradiation 
induced mucositis.8•10•21 What fraction of the flora is involved or which local mucositis sign is 
preventable, is unknown. Attempts have been described to reduce the whole oropharyngeal flora 
by rinsing the mouth with different concentrations of disinfecting agents.22•23 If it is generally 
true that flora plays a promoting or maintaining role in development of mucositis, it seems to 
be useful to evaluate the effect of flora suppression on the mucositis score course. This study 
is now in progress. 
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ABSTRACT 
The constancy of oropharyngeal flora in healthy people is based on intact defence against 
colonization. Conditions which can interfere with this defence are underlying disease and 
medical interventions, and may be associated with alterations in the oropharyngeal flora. The 
oral flora was assessed by means of a modified oral rinse method based on pre-enrichment in 
nutrient medium. The colonization index of the oral cavity was defined as the sum of the 
logarithm 10 of the concentrations of a particular micro-organism isolated from one ml of 
oropharyngeal washing specimens divided by the number of oral washings. This index was 
evaluated as an indicator of ( decreased) colonization defence by comparing a group of healthy 
volunteers with a group of post-surgery head and neck oncology patients. Oral colonization 
indices for Enterobacteriaceae, Pseudomonadaceae and Acinetobacter species as well as for 
Staphylococcus epidermidis were statistically significantly higher in the patient group com­
pared to the volunteers. This clear reduction in colonization defence, resulting in a high carriage 
rate of potentially pathogenic Gram-negative bacilli, may be a result of the combination of 
underlying disease ( cancer) and surgical intervention ( debulking or radical resection of tumor). 
INIRODUCTION 
Normal oropharyngeal flora is made up of a myriad of anaerobes and aero bes including viridans 
streptococci. Each individual carries this indigenous flora in the oral cavity.1 More than half of 
healthy people carry Streptococcus pneumoniae, Haemophilus influenzae and Branhamella 
catarrhalis in their mouth; Staphylococcus aureus and Candida species can be isolated from the 
oral cavity in 20-40% of healthy people.2-3 These species are called 'community' acquired 
strains because of their high prevalence in normal hosts. The oral carriage of Enterobacteri­
aceae, Pseudomonadaceae and Acinetobacter spp. ('hospital' acquired strains) is uncommon 
in healthy people.4 This constancy of oropharyngeal flora is dependent on defence against 
colonization. The oropharyngeal cavity possesses defence mechanisms against colonization 
with aerobic Enterobacteriaceae, Pseudomonadaceae andAcinetobacter spp. and overgrowth 
of yeasts, that are daily acquired from food, beverages etc.5•7 Several factors contribute to this 
colonization defence: integrity of anatomy8 and physiology (e.g. pH of saliva),9 motility (e.g. 
chewing, swallowing),10 secretions,11 secretory immunoglobulin A,12 mucosal cell tumover13 
and indigenous oral flora; 14 all of these factors interacting within the host contribute to an 
effective clearance of Enterobacteriaceae, Pseudomonadaceae, Acinetobacter spp. and yeasts. 
If one of the defence factors is greatly altered then changes might be expected to occur in the 
oral flora.15•16 Conditions which can interfere with this type of defence are e.g. ageing, 
underlying disease,17 medical intervention18 and antibacterial agents.19 These circumstances 
may be associated with alterations in the oropharyngeal flora. 
The aim of this study is to evaluate the measurement of colonization index, using a minimum 
of two oropharyngeal samples as an indicator of decreased colonization defence in the oral 
cavity, using a modified oral rinse method based on pre-enrichment in nutrient medium. These 
methods are illustrated by comparing a group of healthy volunteers with a group of post-surgery 
head and neck oncology patients. 
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MATERIALS and METHODS 
Subjects. All volunteers and patients were aged 55 years and older. They were all edentulous and 
wore full dentures. The head and neck oncology patients had previously (minimally 4-6 weeks 
prior to sampling) undergone surgery for debulking or radical resection of the tumor. These 
patients had been operated only and not been irradiated. Sampling frequency was twice in one 
week on the same days (Monday, Thursday) and same time of the day (9-10 a.m.) for both 
groups. 
Techniques. Quantitative oropharyngeal cultures were obtained by oral washing using 
isotonic saline as the collecting fluid. The subject rinsed and gargled with 10 ml of saline for 30 
seconds and collected it in a sterile vial (Cordis Laboratories, Roden, The Netherlands). From 
this sample 1 ml was added to 9 ml of brain heart infusion (BHI) broth (Lab M, Salford, 
England), to make serial tenfold dilutions. Dilution series were made in trays of 64 (8 x 8) cups 
of 1.5 ml (Thovadec, Ede, the Netherlands) (figure 1). Each cup was filled with 0.45 ml of BHI. 
A 0.05 ml sample from the 1 :  10 diluted oropharyngeal suspension was mixed with 0.45 ml BHI 
in the first cup, resulting into a 1: 100 oropharyngeal suspension. All dilution steps from 10-2 
through 10·9 were prepared in BHI with 0.05 ml microdiluters (Dynatech AG, Zug, Switzer­
land). The oropharyngeal samples were incubated at 37 °C for 18 hours. The number of cups 
showing turbidity due to growth of bacteria indicates the logarithm of the concentration of 
micro-organisms per ml of oropharyngeal washing (quantitative determination). 
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Quantitative tenfold serial dilution method of oropharyngeal washings. 
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Thereafter, all the dilutions with growth were subcultured on MacConkey agar (Gibco 
Limited, Paisley, Scotland), yeast morphology agar (Merck, Darmstadt, West Gennany) and 
blood agar (Gibco Limited, Paisley, Scotland) for qualitative detennination. Enterobacteri­
aceae, P se udomonadaceae and Acinetobacter spp. were evaluated on MacConkey agar, yeasts 
on yeast morphology agar and streptococci and staphylococci on blood agar. Morphologically 
distinct colonies were isolated in pure culture. The identification of Enterobacteriaceae, 
Pseudomonadaceae and Acinetobacter spp. was done by means of the API 20 E test20 (API B. V . ,  
's-Hertogenbosch, The Netherlands), and yeasts were identified as C.albicans by the genn tube 
test. 21 Staphylococci were screened by means of the slide coagulase test.22 All results were 
expressed as the logarithm 10 of colony fonning units (CFU) per ml of oropharyngeal washing. 
Control series. The pre-enrichment oral washing techniques with overnight culture in brain 
heart infusion broth for 18  hours followed by the use of selective solid media were compared 
with the conventional 'direct counting' techniques including direct inoculation onto solid media 
without overnight culture.23 
Definitions. Oropharyngeal carriage. Volunteers or patients having both two samples positive 
for identical micro-organisms are defined as oropharyngeal carriers of that particular micro­
organism. 
Colonization index. The sum of the logarithm 10 of the concentrations of a particular micro­
organism isolated from one ml of oropharyngeal washing, divided by the number of oropharyn­
geal washings is defined as the colonization index of the oral cavity for that particular micro­
organism. 
In this study the carriage and colonization index is calculated for the following micro­
organisms: viridans streptococci, that is all a haemolytic streptococci excluding S.pneumoniae 
(indigenous flora), S.epidermidis (that is all coagulase negative staphylococci), S.aureus, yeasts 
('community' flora) and Enterobacteriaceae, Pseudomonadaceae and Acinetobacter spp. 
('hospital' strains). 
Statistical analysis. The carriage in the two groups was compared by the Fisher exact test. For 
comparison of the mean colonization index in the healthy volunteers and the patient group the 
randomization version of the Student t-test was used. 24 The tests were perfonned at 5% 
confidence limits, two-sided. The sensitivity of the techniques was defined as the percentage 
ratio of total positive results divided by the sum of total positive results plus false negative 
results.25 
RESULTS 
A total number of 52 oropharyngeal samples were collected from 26 subjects: 12 healthy 
volunteers (6 females, 6 males) and 14 patients (3 females, 11 males) who have head and neck 
cancer. Median age was 65. 5 years (range 56-76 years) in the volunteer group. The patient group 
had a median age of 66. 5 years (range 55-87 years). 
Carriage (figure 2). All volunteers and patients carried viridans streptococci. S.aureus was 
not isolated from either the volunteer or the patient group. There was a difference in oral carriage 
of S.epidermidis in the volunteer group (0%) compared with the patients (21 % ), however, it was 
not a significant difference at the 5% level. Four of the 12 healthy volunteers carried yeasts 
(33%) whereas three patients (21 %) were colonized by yeasts. One volunteer out of twelve 
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Figure 2: 
The difference of oropharyngeal carriage for Eruerobacteriaceae, Pseudomonadaceae andAcinetobacter 
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Figure 3: 
A significant difference was observed in the colonization indices for Enterobacteriaceae, 
Pseudomonadaceae andAcinetobacter species as well as for Staphylococcus epidermidis (p<0.01) for the 
patients who have head and neck cancer compared to the healthy individuals. 
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the oral cavity, while eight patients out of fourteen (57%) were found to be persistently colonized 
with these micro-organisms at this site (p<0.01). 
Colonization index (figure 3). The colonization index of the oropharynx for viridans strep­
tococci was 4.7 (s.d. 0.7) in the volunteer group and 4.9 (s.d. 1.1) in the patient group. For 
S.epidermidis the colonization index was 0.2 (s.d. 0.8) versus 1.5 (s.d. 1.9), this difference was 
significant p<0.01. There was no significant difference between the yeast indices of the 
oropharynx of the two groups studied (0.9, s.d. 1.2 for the healthy volunteers versus 0.6, s.d. 1.1 
in the patients). However, a significant difference was observed in the colonization index for En­
terobacteriaceae, Pseudomonadaceae andAcinetobacter spp. between volunteers (0.2, s.d. 0.6) 
and patients (1.0, s.d. 1.0) (p<0.01). 
Controls (tables I and 2). A comparison of the rate of detection of oral Gram-negative bacilli 
carriage by the oral rinse culture techniques without versus with overnight incubation in nutrient 
medium is shown in table 1. The sensitivity of the overnight culture technique was significantly 
higher than the technique without overnight culture in broth (p<0.01). 
Table 1: A comparison oforal washing techniques without and with overnight culture in nutrient medium 
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On detailed analysis of the results it was noted that the conventional oral rinse culture 
techniques, i.e. without overnight incubation, yielded negative results on six occasions. On all 
six occasions the lowest concentration of 101 bacterial cells per ml of saliva was recovered by 
means of the overnight techniques. The superior sensitivity of the overnight culture techniques 
compared with the conventional method of 'direct counting' to detect oral carriage of Gram­
negative bacilli, yeasts and Staphylococcus epidermidis is shown in table 2. 
Table 2: The relative recovery rates of Enterobacteriaceae, Pseudomonadaceae, Acinetobacter spp, 
Staphylococcus epidermidis, yeastspp., viridans streptococc, and Staphylococcus aureus by the 



























The oral washing method described in this study is a modification of the technique used by 
Johnston and Bodey.23 It is now seventeen years since these investigators demonstrated that a 
gargle method is superior to the swab,26 platinum loop27 and gelatin syringe221 methods, for three 
reasons. (1) Gargling permits sampling of surfaces of the entire oropharyngeal cavity including 
tonsillar crypts and possibly otherwise inaccessible areas. (2) Using a defined volume of saline 
and letting the subject gargle for a specified period of time, there is a minimal variation in 
sampling. (3) The mean concentrations of micro-organisms received from gargle samples were 
higher than the mean concentrations of micro-organisms obtained by the swab technique. 
However, Johnston and Bodey were in doubt about the sensitivity of their method, because 
micro-organisms present in very low concentrations were not detected.29 To enhance the 
sensitivity of the saline gargle method we made nine tenfold dilution steps in BHI broth30 and 
immediately incubated this dilution series at 37 °C for 18 hours, while the original technique 
included five dilution steps in saline from which 0.1 ml of each dilution was inoculated onto 
blood agar followed by incubation at 37 °C for 24 hours. In the modified method of this study 
the number of cups showing turbidity due to growth of bacteria indicates the concentration of 
micro-organisms present per ml of gargle sample. All cups with growth were inoculated on three 
types of media in order to differentiate the micro-organisms for which to screen. In the Johnston/ 
Bodey method colony counts of each morphological type of organism were made on the blood 
agar plate and expressed as the total number of organisms recovered per ml of sample. The 
sensitivity of our method is further increased by the 18  hours of incubation in BHI broth 
immediately after collecting the sample ('enrichment' step), which permits detection of very 
low concentrations of micro-organisms. The technique of pre-enrichment followed by the use 
of selective solid media has been described for the isolation of small numbers of salmonellae31 
and antibiotic-resistant bacteria from faeces.32 The conventional technique without overnight 
culture is based on the concept that the dynamics of microbial growth in a mixed culture system 
are unpredictable. Gram-negative bacilli are reported to proliferate more rapidly than e.g. Gram­
positive cocci. The enrichment method developed for this study basically relies on that latterob­
servations. Detection of oropharyngeal carriage of Gram-negative bacilli in low concentrations 
was the major aim of the use of the rinse culture technique with overnight culture, because 
oropharyngeal Gram-negative bacillary carriage is a sensitive marker of underlying disease. 
Samaranayake et al. reported that conventional 'direct counting' of oral washing samples after 
centrifugation was a more sensitive method than the Johnston & Bodey technique of neat oral 
washing sample per se.25 The sensitivity of the concentrated rinse culture method is comparable 
with the sensitivity found for the enrichment method. 
In the literature widely different figures are reported for the prevalence of particular micro­
organisms in healthy subjects1•18 and other populations.17• 18• 33• 37 This may be due to the fact that 
many studies were limited to single culture surveys: transient colonization may explain these 
variations. Multiple successive culture surveys are more informative and reliable, with refer­
ence to oropharyngeal carriage and colonization index. Carriage implies a resident oral 
colonization pattern of minimally one week. Detection of carriage requires a minimum of two 
saline gargle samples in a week. The colonization index takes into account not only the type of 
a specific micro-organism but also the concentration of that micro-organism present in the 
sample over a specific period of time. This index is very useful to monitor the effect of e.g. 
antibiotic prophylaxis or therapy on the oropharyngeal colonization pattern. 
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Monitoring two groups with this method two findings emerge that require comment: 
I. Both carriage and colonization index for Enterobacteriaceae, Pseudomonadaceae andAcine­
tobacter spp. as well as oral colonization index for S.epidermidis were significantly higher in 
the patients than in the healthy population of the same age. A clear reduction in colonization 
defence is the conclusion. This may be due to the combination of underlying disease (cancer) 
and medical intervention (surgery). Oropharyngeal colonization with Enterobacteriaceae, 
Pseudomonadaceae and Acinetobacter spp. is reported to occur frequently in alcoholic 
patients,33 patients suffering from diabetes34 or chronic bronchitis35 and in patients who had 
undergone orthopedic surgery.18 The percentages described were in general about 30%. So, the 
57% observed in our study are probably a result of a combination of local disease and surgery. 
Data on S.epidermidis are not available in the literature. The oral colonization index for this 
micro-organism of low pathogenicity is probably of value for detection of decreased coloniza­
tion defence. 
II. No difference was found in carriage and colonization index with yeasts between the patient 
(21 %, 0.9) and the healthy (33%, 0.6) populations. Apparently the underlying disease and 
surgery do not increase Candida spp. carriage and colonization index. It remains unclear why 
impaired colonization defence mechanisms of the oral cavity are associated with a significantly 
higher carriage and colonization index for Enterobacteriaceae, Pseudomonadaceae, Acineto­
bacter spp. and S.epidermidis and not for yeasts. Further, no insights are available why a specific 
subset of patients among a diseased population experience consistent colonization with 
Enterobacteriaceae, Pseudomonadaceae, Acinetobacter spp. and S.epidermidis while others 
have none at all. 
In summary, a modified oral rinse method based on enrichment in nutrient medium was found 
to be superior to the conventional direct counting technique after evaluation of 52 oral rinses 
collected from 26 individuals. The modified technique allowed detection of decreased oro­
pharyngeal colonization defence in the 14 patients with head and neck cancer versus 12 healthy 
individuals via significantly increased colonization indices for Enterobacteriaceae, Pseudo­
monadaceae, Acinetobacter species and S.epidermidis in the diseased group. 
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ABSTRACT 
Oral flora is thought to contribute to irradiation mucositis in head & neck cancer patients. 
Neglect of oral hygienic care may also contribute to mucositis. The purpose in this prospective, 
randomized, placebo controlled, double blind study was to evaluate the effect of chlorhexidine 
0.1 % mouthrinses on oral flora and irradiation mucositis. This study included 30 head & neck 
oncology patients, with comparable irradiation portals. One group (n=lS) rinsed four times 
daily with chlorhexidine 0.1 %, the other group (n=15) with a placebo. The oral flora was 
cultured (oral washing technique) twice before and thrice weekly during the period of radiother­
apy. At the same days the severity of mucositis was determined. 
Colonization index of viridans streptococci was significantly reduced only after five weeks of 
chlorhexidine 0.1 % treatment The colonization patterns of Candida species, E faecalis, 
staphylococci, Enterobacteriaceae, Pseudomonadaceae and Acinetobacter species were not 
influenced by five weeks of use of chlorhexidine rinses compared to the placebo. No differences 
were seen in the development and severity of mucositis between the two study groups. 
In conclusion, oral flora suppression and lowering the severity of mucositis by means of 
disinfecting mouth rinses was not successful. 
INTRODUCTION 
Patients suffering from cancer in the head and neck area can be treated with surgery, radiother­
apy or a combination of both treatment modalities. A well known side effect of irradiation is 
mucositis. 1•3 Oral mucositis is defined as the inflammatory-like changes of the oral mucosa due 
to a direct effect of radiotherapy .4.5 Intensive supervised oral hygiene programmes are supposed 
to be effective in minimizing oral complications during irradiation. Cleansing of necrotic cells 
and debris is the major aim of frequent rinsing.6-9 Since micro-organisms are thought to enhance 
mucositis due to irradiation,10 disinfecting agents are often added to these rinsing fluids. 
Chlorhexidine is commonly used for elimination or reduction of oropharyngeal flora in irradi­
ated patients.11 
Controlled studies on the effect of chlorhexidine rinsing on the oropharyngeal flora are 
scarce; microbiological investigations were confined to indigenous oral flora including viridans 
streptococci.Yeasts were studied because they are the most important micro-organisms causing 
stomatitis. 
We started a prospective, randomized, placebo controlled, double blind study, to the effect of 
chlorhexidine 0.1 % rinses on viridans streptococci, yeasts, Enterococcus faecalis, as well as 
Enterobacteriaceae, Pseudomonadaceae, Acinetobacter spp. and staphylococci. 
MATERIALS and METHODS 
Patients. Head and neck cancer patients with identical irradiation portals to the oropharyngeal 
areas were eligible for this study. All patients participating this study were obtained by informed 
consent. The study patients received external bilateral irradiation, 2 Gy daily, for a total dose of 
at least 50 Gy (midline dose). The irradiation portals were such that the major salivary glands 
(parotid and submandibular) were included. The policy outlined by the oncology team was 
based on a combined surgery-irradiation approach in this group of patients. Radical resection or 
de bulking of the primary tumor often preceded the irradiation course. 
All patients received a preradiotherapy dental examination. Dental treatment deemed necess-
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ary to eliminate foci of infection or mechanical irritation was performed as required, with 
appropriate precautions. This included, provisional restoration of gross decay, removal of calcu­
lus deposits, smoothing of sharp restorations or cusps, and endodontic treatment of nonvital 
teeth. Edentulous patients were not allowed to wear their prostheses,7•12 while dentate patients 
applied daily a neutral fluoride gel by means of custom-made trays.13•14 
Hygiene programme. The oral cavity of all patients was sprayed daily by an oral hygienist 
during the course of radiotherapy. The oral hygienist carefully cleansed all mouth areas in this 
way. The patients rinsed their mouths by themselves as well for I minute, three times a day. 
Study design. The study was a prospective, double blind, randomized, placebo controlled 
programme. Half of the patient population received the spray/rinsing programme with 
chlorhexidine 0.1 %. The second group rinsed and sprayed with a placebo solution containing 
identical flavouring agents and into which was incorporated 0.015% quininechloride. The latter 
component was added to produce a slightly astringent quality comparable to that of the 0.1 % 
chlorhexidine solution. No antibacterial activity of the placebo solution could be measured in 
vitro. The amount of fluid sprayed and rinsed was about 100 ml per day (spraying 50 ml, rinsing 
three times 15 ml). 
Scoring and monitoring of mucositis. The mucositis was evaluated in a semi-quantitative 
way, starting on the first irradiation day and thrice weekly afterwards (Monday, Wednesday, 
Friday). The details of the scoring technique are described elsewhere. 15 
Oropharyngeal flora sampling. Before the beginning of radiotherapy, the oral cavity of all 
patients was sampled twice by the gargling method (base-line cultures). During the irradiation 
course the gargle sampling frequency was thrice weekly at the same days of mucositis scoring 
( surveillance cultures). The quantitative oropharyngeal cultures were obtained by oral washing 
using isotonic saline as the collecting fluid. The subject rinsed and gargled with IO ml of saline 
during 30 seconds and collected it in a sterile vial (Cordis Laboratories, Roden, The Nether­
lands). The samples were obtained between 8.00 and 9.00 a.m. on the sample days and worked 
out in the laboratory within one hour. 
Microbiological methods. One ml of the sample was added to 9 ml of brain heart infusion 
(BHI) broth (Lab M, Salford, England), to make serial tenfold dilutions. Dilution series were 
made in trays of 64 (8x8) cups of 1.5 ml (Thovadec, Ede, The Netherlands). Each cup was filled 
with 0.45 ml of BHI. A 0.05 ml sample from the 1: 10 diluted oropharyngeal suspension was 
mixed with 0.45 ml BID in the first cup, resulting in a 1:100 oropharyngeal suspension. All 
dilution steps from 10·2 through 10·9 were prepared with 0.05 ml microdiluters (Dynatech AG, 
Zug, Switzerland). 
The oropharyngeal samples were incubated at 37°C for 18 hours. The number of cups show­
ing turbidity as a result of growth of bacteria indicated the logarithm of the concentration of 
micro-organisms per ml of oropharyngeal washing, that is quantitative determination. There­
after, all dilutions with growth were subcultured on MacConkey agar (Gibco Limited, Paisley, 
Scotland), yeast morphology agar (Merck, Darmstadt, West Germany), kanamycin aesculin 
agar (Lab M, Salford, England) and blood agar (Gibco Limited, Paisley, Scotland) for qualita­
tive determination. Enterobacteriaceae, Pseudomonadaceae and Acinetobacter spp. were eva­
luated on MacConkey agar, yeasts on yeast morphology agar,Efaecalis on kanamycin aesculin 
agar and streptococci and staphylococci on blood agar. Morphologically distinct colonies were 
isolated in pure culture. The identification was done by standard microbiological techniques. 16 
Definitions. Carriage of a particular micro-organism was defined as the condition in which a 
study patient showed a minimum of two consecutive oral washings positive for that micro­
organism. 
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Table 1 a: Patient data placebo treated group. 
patient age gender type neoplasm* surgery irrad.dose (Gy) 
1 43 f sec yes 50 
2 44 m ac yes 66 
3 66 m sec yes 66 
4 87 f sec yes 66 
5 65 m sec yes 66 
6 65 f sec no 66 
7 33 f ac yes 66 
8 60 m sec yes 66 
9 43 m sec yes 66 
10 55 f nhl no 50 
1 1  65 m sec yes 66 
12 40 m sec yes 66 
13 48 m nhl no 50 
14 56 m sec yes 68 
15 42 m sec yes 66 
mean f :  m yes : no 
54.1 1 :  3 12 : 3 
* sec = squamous cell carcinoma 
ac = adenocarcinoma 
nhl = non-Hodgkin lymphoma 
Table 1 b: Patient data chlorhexidine 0.1 % treated group. 
patient age gender type neoplasm* surgery irrad.dose (Gy) 
16 77 f sec yes 70 
17 42 f ac yes 66 
1 8  85 f sec yes 68 
19 71 f sec yes 66 
20 70 m ac yes 66 
21 40 m sec yes 66 
22 61 m sec yes 66 
23 49 m sec yes 66 
24 76 m mfh yes 66 
25 50 f sec no 66 
26 55 m sec yes 66 
27 72 m sec yes 66 
28 67 f sec yes 66 
29 59 m sec no 66 
30 54 m sec yes 66 
mean f :  m yes : no 
61 .9 2 :  3 13 : 2 
* sec = squamous cell carcinoma 
ac = adenocarcinoma 
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Colonization index of the oral cavity was defined as the sum of logarithm of the concentra­
tions of a particular micro-organism isolated from 1 ml oforal washing specimens divided by the 
number of oral washings. 
Statistical analysis. The carriage in the two groups was compared by the Fisher exact test. The 
tests were performed at the 5% confidence limits, two-sided. For comparison of the mean colo­
nization index and mucositis score in the chlorhexidine treated group and the placebo treated 
group the randomization version of the Student t-test was used.17 
RESULTS 
Patients. Thirty patients (tables la  and b) participated the study. Both groups did not show 
significant differences in age, sex, malignant neoplasm, prior surgery and total dose of irradi­
ation. In each group thirteen patients were edentulous and two were dentate. All patients re­
ceived identical midline doses of al least 50 Gy. The two study groups were compared for five 
weeks of irradiation protocol, until each had received 50 Gy (2 Gy daily, 5 times a week). 
Microbiology. Figures la and lb represent viridans streptococci carriage and colonization 
index. All patients carried viridans streptococci in high concentrations before starting radiother­
apy. There was no influence on the carriage rate, while only at the end of treatment with 
chlorhexidine 0.1 %, a significant reduction of the colonization index was seen compared to the 
placebo group (p<0.05). 
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Figure 1 a: 
Carriage of viridans streptococci for the 
chlorhexidine and placebo group during radiation 
therapy. 
Figure 1 b: 
Colonization index of viridans streptococci for 
the chlorhexidine and placebo group during 
radiation therapy. 
Figures 2a and 2b depict S.epidermidis carriage and colonization index. Twenty percent of 
the patients carried S.epidermidis in the lowest concentration. No difference was observed in the 
two study populations before onset of the irradiation course. Chlorhexidine 0.1 % did not alter 
the colonization patterns, nor the number of patients colonized (2a) neither the growth densities 
(2b). 
Figures 3a and 3b show the S.aureus results. The number of carriers and the oral concentra­
tions were very small. Chlorhexidine 0.1 % seemed to have a slight effect there was one carrier 
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Figure 2 a: 
Carriage of S.epidermidis for the chlorhexidine 
and placebo group during radiation therapy. 
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Figure 2 b: 
Colonization index of S.epidermidis for the 
chlorhexidine and placebo group during radiation 
therapy. 
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Figure 3 a: 
Carriage of S.aureus for the chlorhexidine and 
placebo group during radiation therapy. 
Figure 3 b: 
Colonization index of S.aureus for the chlor­
hexidine and placebo group during radiation ther­
apy. 
Figures 4a and 4b show the findings for Efaecalis. About 15% of the patients carried 
Efaecalis in their mouth, in both groups. The colonization index was very low. No significant 
difference in both carriage and colonization index was observed during chlorhexidine treatment. 
Figures 5a and 5b represent Candida spp. carriage and colonization index. At inventory 20% 
of the patients of both study groups were yeasts carriers. The concentration was minimal. No 
difference in mean percentage of carriers and in mean colonization index was measured during 
the period of irradiation between the chlorhexidine positive and negative group. There were two 
placebo patients who suffered Candida stomatitis during irradiation: one patient developed 
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Figure 4 a: 
Carriage of Efaecalis for the chlorhexidine and 
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Figure 4 b: 
Colonization index of Efaecalis for the chlor­
hexidine and placebo group during radiation ther­
apy. 
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Figure 5 a: 
Carriage of Candida species for the chlorhexidine 
and placebo group during radiation therapy. 
Figure 5 b: 
Colonization index of Candida species for the 
chlorhexidine and placebo group during radiation 
therapy. 
of saliva) and the other patient at day 36 (50 Gy, corresponding with 105 colony forming units of 
Candida spp. per ml of saliva), respectively. Both were treated successfully with 10 days of oral 
lozenges of amphotericin B 10 mg, four times a day. No stomatitis caused by Candida spp. was 
seen in the chlorhexidine treated group. 
Figures 6a and 6b depict carriage and colonization index of Enterobacteriaceae, Pseudo­
monadaceae and Acinetobacter species. A high carriage rate up to 57% was found in the two 
patient groups. The colonization index was 1 in both groups. No effect of chlorhexidine 0.1 % 
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Carriage of Enterobacteriaceae, Pseudomonada­
ceae and Acinetobacter species for the chlor­
hexidine and placebo group during radiation ther­
apy. 
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Figure 6 b: 
4 � 
T (weeks) 
Colonization index of Enterobacteriaceae, 
Pseudomonadaceae and Acinetobacter species 
for the chlorhexidine and placebo group during 
radiation therapy. 
Scoring mucositis. No difference in development and severity of oral mucositis was meas­
ured with the semi-quantitative scoring technique between the two groups. Out of the total study 
population, 24 patients (80%) showed the most severe stage of pseudomembrane formation 
(twelve in the placebo treated group, twelve in the chlorhexidine 0.1 % group). The two patients 
developing Candida stomatitis suffered all mucositis stages including pseudomembranes. 
DISCUSSION 
The answer on the major question of this study whether chlorhexidine 0.1 % rinses reduces the 
oropharyngeal flora in this group of patients is negative. Apart from the viridans streptococci, 
there was no reduction in percentage of carriage and in colonization index for the micro­
organisms sought between the two groups with and without chlorhexidine 0.1 %. Moreover, no 
difference was observed in mucositis between both groups. 
A discrepancy is found between in vitro and in vivo studies. Chlorhexidine 0.1 % is known to 
be active against Gram-positive and Gram-negative micro-organisms and yeasts based on in 
vitro studies.18 In vivo two other factors determine microbiologically active chlorhexidine con­
centrations: (1) inactivation by food compounds, bacteria, fibre and proteins and (2) contact time 
between micro-organisms and chlorhexidine 0.1 %. Rinsing and spraying do not guarantee a 
proper contact between antimicrobial agents and oral micro-organisms.19•20 Moreover, rinsing 
and spraying every six hours permits the oral micro-organisms - perhaps temporarily suppressed 
but definitely not eradicated - to overgrow and to reach original concentrations. Literature 
reveals that chlorhexidine rinses are associated with oropha..-yngeal concentrations of 
chlorhexidine that would be sufficient to kill micro-organisms even hours after rinsing,21•22 as 
well as with a chlorhexidine reservoir formation in the oral cavity. 23,2A The fact that these studies 
are based on radio labelled chlorhexidine21 and that no microbiological tests were used to meas­
ure oral chlorhexidine concentrations may explain the discrepancy between our results and these 
literature findings. 
Much of the work on the effect of chlorhexidine mouth rinses on salivary flora is done in 
human volunteers in Denmark by Rindom Schi0tt and associates. This group reports in four 
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articles a reduced count of aerobic salivary micro-organisms during chlorhexidine mouth rinses. 
These reductions observed were estimated in percentages of the baseline flora. Different values 
varying between 90% and 30% reduction of the original flora were found. 25-Z1 No reduction was 
seen at all in the study using 2% of chlorhexidine solution.28 The conclusions of the group that 
"although the number of bacteria in saliva was markedly reduced, large numbers still per­
sisted"25 are confirmed by our results (Rindom Schi0tt, 1970). The micro-organisms studied in 
the literature were viridans streptococci, anaerobes and yeasts. 26•29.3° These micro-organisms as 
well as Efaecalis and S.aureus belong to the indigenous and 'community' acquired flora. If a 
reduction was observed during chlorhexidine 0.1 % treatment, it was mainly among this Gram­
positive micro-organisms. Our study also included the family of Enterobacteriaceae, Pseudo­
monadaceae and Acinetobacter spp., uncommon in the oropharynx of healthy people.17 
Chlorhexidine mouth rinses did not reduce the salivary concentrations of Enterobacteriaceae, 
Pseudomonadaceae and Acinetobacter spp. in our study. To our knowledge, no reports in the 
literature are available about the reducing effect of chlorhexidine rinsing on the salivary titers of 
these potential pathogenic micro-organisms. 
From clinical microbiological point of view, overt stomatitis caused Candida albicans was 
only encountered in two patients in the control group. Although four times daily mouth rinses 
with chlorhexidine 0.1 % were not effective in producing a decrease in mean oral carriage and 
colonization index for yeasts, the clinical observations suggest that the intensively supervised 
oral hygiene programme including chlorhexidine mouth rinsing may have valuable applications 
in the control of Candida stomatitis in head and neck cancer patients suffering irradiation 
mucositis. Similar findings are reported in leukemia patients with oral complications during 
remission-induction chemotherapy .29-31 
No effect on development and severity of oral mucositis was found during this investigation. 
This study cannot answer the question whether or not oral flora contributed to mucositis, be­
cause there was no substantial impact of chlorhexidine on the oropharyngeal flora. A pharma­
ceutical technological application form of antimicrobials guaranteeing a sufficiently long con­
tact time may be associated with a more successful oral flora suppression. Only then, the role of 
flora in mucositis can be evaluated. 
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ABSTRACT 
Chlorhexidine mouth rinsing is commonly used for oral flora reduction. Indigenous micro­
organisms (viridans streptococci) are significantly suppressed, while 'hospital' acquired Gram­
negative bacilli are not affected in vivo. However, chlorhexidine is known to be considerable 
active in vitro also to Gram-negative bacilli. To explain this discrepancy between good in vitro 
and poor in vivo activity of chlorhexidine, minimum bactericidal concentration (MBC) values 
for 120 isolates were studied using a standard dilution method in fresh whole saliva, broth and 
glucose 5%. It turned out that both saliva and broth significantly reduced the bactericidal activity 
of chlorhexidine against all micro-organisms tested as compared to glucose 5% (p<0.01). 
MBC's for indigenous flora were significantly lower than the values obtained for the 'hospital ' 
acquired micro-organisms (p<0.05). These observations of chlorhexidine inactivation by saliva 
may explain why chlorhexidine mouth rinsing is of limited value in decontaminating the oral 
cavity of Gram-negative bacilli. 
INTRODUCTION 
Chlorhexidine mouth rinsing is commonly used to prevent plaque formation,1 to prevent 
mucositis in both chemotherapy2 and irradiation,3 to treat stomatitis caused by yeasts,4 to treat 
recurrent aphthous ulcers5 and gingivitis. 6 The rationale of these indications for chlorhexidine 
rinsing is reduction or elimination of the oropharyngeal flora. There are numerous studies 
showing remarkable in vitro activity of chlorhexidine against practically all micro-organisms, 
including Gram-positive cocci, Gram-negative bacilli and yeasts.7•9 Indigenous, e.g. viridans 
streptococci, and 'community' acquired micro-organisms (Candida species, Staphylococcus 
aureus) are carried by healthy people, whereas carriage of 'hospital' acquired micro-organisms 
(Enterobacteriaceae, Pseudomonadaceae andAcinetobacter species) is uncommon in healthy 
individuals.10•1 1  In vivo studies in both volunteers and patients revealed only a partial elimina­
tion of Gram-positive cocci from the oral cavity, even in the high concentration of chlorhexidine 
of 0.2 %.12•13 No effect at all is observed on oropharyngeal carriage of 'hospital' acquired Gram­
negative bacilli.14 
Several factors may interfere with the effect on oral flora suppression by chlorhexidine 
rinsing. Inactivation by food compounds, dilution by oral secretions and a short contact time 
may determine the real microbiologically active chlorhexidine concentrations in the mouth. 
This study was undertaken in an attempt to explain the discrepancies between good in vitro but 
poor in vivo activity of chlorhexidine mouth rinses. The influence of saliva on chlorhexidine 
activity on various micro-organisms was determined in vitro. 
MATERIALS and METHODS 
Saliva. Fresh stimulated whole saliva from one and the same healthy person was obtained at the 
same time at each test day (between 9.00 a.m.-10.00 a.m.). The saliva was obtained by chewing 
parafilm and collected in a sterile vial. The volunteer did not carry Staphylococcus epidermidis, 
Staphylococcus aureus, Enterococcus faecalis, Enterobacteriaceae, Pseudomonadaceae and 
Acinetobacter species neither yeasts. One ml of saliva contained only indigenous oral flora, i.e. 
106 colony forming units (CFlJ) of viridans streptococci (106 Streptococcus salivarius, 104 
Streptococcus mutans) and 108 CFU of various anaerobic species (total streptococci 108, 105 
Actinomyces spp., 106 Veillonella spp.). Table 1 depicts the sialochemistry findings of the 
saliva used. 
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Table 1 :  Sialochemistry values of used saliva samples in the inactivation experiments. 
average s.d. 
Sodium mmol/1 5.7 1 .4 
Potassium mmol/1 22.3 0.5 
Calcium mmol/1 0.92 0.05 
Chloride mmol/1 10.3 1.4 
Phosphate mmol/1 4.62 0.19 
Urea mmol/1 4.5 0.7 
Amylase g/1 0.24 0.07 
Total protein g/1 1 .55 0.26 
Broth. Susceptibility testing was performed according to standardized broth dilution pro­
cedure. 15 For this purpose trypticase soy broth (TSB, Oxoid LTD, Basingstoke, England) was 
used and TSB diluted with fresh whole saliva, i.e. TSB diluted with the same amount of saliva 
(50% TSB + 50% saliva). 
Control solution. As protein free solution glucose 5% was used being a normal compound 
of fresh whole saliva. 
Chlorhexidine. Chlorhexidine was obtained as a 20% aqueous solution of chlorhexidine 
digluconate (Hibitane, I.CJ., Rotterdam, The Netherlands). From this solution a dilution of 
0.5% chlorhexidine was made in deionized water which was used in the inactivation experi­
ments. 
Micro-organisms. Ten different strains of twelve different species of micro-organisms were 
tested: Efaecalis, S.epidermidis, E.coli (indigenous), Candida albicans, S.aureus 
('community'), Klebsiella, Proteus, Enterobacter, Pseudomonas, Serratia, Acinetobacter and 
Citrobacter spp. ('hospital' acquired). All hundred and twenty strains were obtained from 
clinical specimens processed in the Department of Oral Microbiology of the University Hospital 
Groningen and the Royal Liverpool Childrens Hospital Alder Hey. An overnight culture (109 
CFU per ml) was obtained by inoculation of the test strain in 9 ml brain heart infusion (BHI) 
broth (Lab M, Salford, England) and incubation for 18 hours at 37°C. The overnight cultures 
were centrifuged at 3000 rpm for 5 minutes. After decanting the supernatant, the pellet was 
resuspended in deionized water and diluted in deionized water to a concentration of 106 CFU 
per ml. Using this concentration, four suspensions of 105 CFU/ml of the test micro-organism 
were made by adding 1 ml to 9 ml of glucose 5%, of TSB, of 50% TSB in 50% saliva and of fresh 
whole saliva, respectively. 
Testing chlorhexidine activity by means of MBC. The activity of chlorhexidine was determined 
by means of the minimum bactericidal concentration (MBC), the minimum concentration of the 
drug required to accomplish irreversible inhibition, i.e. killing after subculturing on solid media. 
The MBC of chlorhexidine was determined in four different suspensions for ten different strains 
of the twelve different species of micro-organisms used. The experiment was carried out in the 
course of 24 test days. On each day enough fresh stimulated whole saliva was collected from 
one and the same healthy volunteer. On each test day five strains of one type of micro-organism 
could be tested in the four different suspensions. In these techniques a tray (figure 1) with 64 
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Figure 1 :  
Determination of MBC's by the tray method. Chlorhexidine was added to cup A l .  Two-fold dilution steps 
were made into both directions from left to right and from the top downward, resulting in identical 
concentrations along slopes (e.g. AS - D5). 
(8x8) cups of 1 .5 ml was used (Thovadec,Ede, The Netherlands). Half a tray was used for testing 
chlorhexidine activity against one test micro-organism in the presence of one of the four 
suspensions. The first row of the tray (i.e. Al-DI) was filled with 0.45 ml of the bacterial 
suspension except cup A 1. All four cups of the other rows (from row A2-D2 to A8-D8) were 
filled with 0.225 ml of the identical bacterial suspension. Cup Al  was filled with 0.95 ml of the 
bacterial suspension to which 0.05 ml of chlorhexidine 0.5% was added. Cup Al contained a 
total of I ml of suspension with 0.025% chlorhexidine, i.e. 250 mg/I chlorhexidine in the first 
cup. With a Finnpipette (Lamers & Pluyer, 's Hertogenbosch, The Netherlands) 2-fold dilution 
steps (0.45 ml) were made from Al to DI. Starting with a concentration of 250 mg/I 
chlorhexidine, a concentration of3 l mg/I was obtained in this way in cup DI.  Analogously, with 
a W.H.O. 4-channel pipette (Amstelstadt, Amsterdam, The Netherlands) 2-fold dilution steps 
(0.225 ml) were made from Al to A8; from B l  to B8; from Cl to C8 and from DI  to D8. This 
results in a concentration of 2 mg/I in cup A8 and 0.3 mg/I in cup D8. In this way identical 
concentrations of chlorhexidine were reached along slopes from e.g. cup A8 to D5. Using this 
method two trays were needed for testing chlorhexidine against one micro-organism in glucose 
5%, TSB, 50% TSB in 50% saliva and in whole saliva. The trays were incubated for 18 hours 
at 37°C for Gram-negative bacilli and two nights for Gram-positive cocci and yeasts. After 
incubation all trays were subcultured on MacConkey agar (Gibco Limited, Paisley, Scotland) 
for Gram-negative bacilli, on Staphylococci 110 agar (Merck, Darmstadt, West-Germany) for 
staphylococci, on kanamycin aesculin agar (Lab. M, Salford, England) for Efaecalis and on 
yeast morphology agar (Merck, Darmstadt, West-Germany) for yeasts. The first slope which 
showed no colony growth gave the MBC of chlorhexidine tested for that micro-organism. In 
order to exclude a possible cidal effect of the four different media, all tests were controlled by 
subculturing the strains without chlorhexidine for 18 hours at 37°C. The dilution series were 
subcultured on the above mentioned solid media. 
Analysis of results. For statistical analysis of the results repeated-measures analysis of 
variance was applied, after logarithmic transformation of the measured MBC values. A 5% or 
less level of significance was considered. 
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RESULTS 
Four hundred and eighty susceptibility tests were perfonned on one hundred twenty strains in 
the presence of four different media. The results of susceptibility testing are summarized in 
figure 2. This figure displays median MBC values for each of the twelve different species under 
each of the four solutions. To obtain approximate 95% lower/upper confidence limits, one 
should divide/multiply the medians by 2 for glucose 5% and whole saliva, for TSB and 50% TSB 
in 50% saliva by 1 . 5. 
Saliva, 50% TSB + 50% saliva and TSB significantly reduced the killing action of 
chlorhexidine against all micro-organisms compared to glucose 5% (p<0. 01). The MBC values 
of chlorhexidine for Candida species, S.aureus, Efaecalis and S.epidermidis in fresh whole 
saliva (range 10-32 mg/I) were significantly lower compared to the values of the Gram-negative 
bacilli (range 20-62 mg/I) (p<0. 05). Only the MBC's of chlorhexidine for E.coli were 
comparable to the MBC's for the indigenous and 'community' micro-organisms. The control 
test without chlorhexidine did not show any inhibiting effect of one of the four media on the 120 
strains in our test system. 
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Figure 2: 
MBC's of chlorhexidine in glucose 5%, fresh whole saliva, trypticase soya broth (TSB), and 50% fresh 
whole saliva in TSB against micro-organisms indigenous, 'community' and 'hospital' acquired. Fresh 
whole saliva, 50% TSB in 50% saliva, and TSB significantly reduced the killing action of chlorhexidine 
against all micro-organisms compared to glucose 5% (p<0.01). MBC's for indigenous and 'community' 




The aim of this study was to evaluate whether chlorhexidine inactivation by saliva may be one 
of the factors that might explain the discrepancies between the successful killing action of 
chlorhexidine in vitro and the disappointing oral flora suppression in vivo. The results of this 
study show a profound influence of saliva on the cidal action of chlorhexidine against all 
microbes tested. The MBC values of chlorhexidine in saliva for Gram-positive cocci and yeasts 
are found to be significantly lower than for Gram-negative bacilli. These findings are in 
accordance with the clinical observations reported by Bemhoft and Skaug3 and recently 
confirmed by our group.14 
We have investigated, by a standard 'dilution' test, the minimum bactericidal concentration 
of chlorhexidine against a wide range of bacterial genera, indigenous, 'community' and 
'hospital' acquired flora. Numerous studies on chlorhexidine suspectibility were performed 
using another type of method (e.g. plate) and/or broth (e.g. Muller-Hinton) and incorporating 
the use of Tween 80 to inactivate residual chlorhexidine (possibility of carry over). 16•17 The test 
we applied is generally recommended by Washington and Sutter,15 and is using trypticase soy 
broth without neutralization. The reason we preferred the American standard test is to try to 
mimic as much as possible in vivo (oropharyngeal) conditions. After getting the results 
displaying gross differences between indigenous, 'community' and 'hospital' flora, we believe 
that the different methodology does not matter to explain our in vivo findings. 
Two reports on the effect of saliva on chlorhexidine are available in the literature.13•1 8  
Hesselgren et al. 18 studied the effect of chlorhexidine in sterilized saliva on two micro-organisms 
Efaecalis and C.a/bicans. Whole fresh saliva was used by Sharon et al.13 to evaluate the 
chlorhexidine inactivation by saliva against C.albicans. Hesselgren et al. reported higher 
concentrations of chlorhexidine to be needed to kill Efaecalis and C.albicans in the presence 
of saliva than in aqueous suspensions. 18 Sharon et al. found no inactivation, possibly due to the 
low saliva concentration of 40% combined with an excess of chlorhexidine. 13 Our test system 
aimed at mimicing in vivo conditions of the mouth environment. Whole fresh saliva containing 
proteins, glucose and indigenous micro-organisms was used for this reason. Whole fresh saliva 
is shown to possess antibacterial activity depending on lysozome, secretory immunoglobulin A, 
lactoferrin and Klebanoff factor.19-21 In our system the controls did not show any antimicrobial 
activity of saliva at its own. Most of these antagonistic activities of saliva are minimal and are 
in vitro findings depending on many factors. Whether this salivary antibacterial activity is of 
major importance in vivo is still subject of discussion. 
Neither Hesselgren et al. nor Sharon et al. used the generally recommended broth dilution 
procedures to determine MBC' s of antimicrobial agents. From a microbiological point of view 
we followed Lindemann 's recommendation of testing susceptibility in TSB.22 Finally, MBC's 
should be measured in stead of MIC's (minimal inhibiting concentration) because in the 
oropharyngeal cavity there are no leucocytes to support the antimicrobial activity of chlor­
hexidine. Killing of oral micro-organisms in vivo is depending on the cidal action of the dis­
infecting agent at its own. MIC's are sufficient for antibiotics secreted in organ systems where 
Ieucocytes are mobilized in case of infection (i.e. cystitis, bronchopneumonia, sepsis). 
Much work on chlorhexidine in both volunteers and patients was done by Scandinavian 
groups in the seventies and was concentrated on indigenous and on 'community' acquired 
flora.23 This type of bacteria were also studied by Sharon et al. and Hesselgren et al. 13•1 8  in their 
saliva inactivation studies. Our study included micro-organisms of indigenous, 'community' 
and 'hospital' flora. The increase in MBC values for all types of microbes resulted in salivary 
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MBC's which might be sufficient for in vivo control of indigenous and 'community' flora. 
However, oral suppression of 'hospital' acquired micro-organisms such asEnterobacteriaceae, 
Pseudomonadaceae and Acinetobacter species is unlikely to be successful with chlorhexidine 
due to inactivation by saliva. 
To clarify the underlying mechanism of chlorhexidine inactivation by saliva was not the aim 
of the study. It seems plausible that interactions between chlorhexidineand protein are involved. 
Saliva contains high concentrations of albumin and mucin.2A,25 Further work is in progress on 
these interactions. 
Chlorhexidine 0.1 % mouth washes were associated with a complete absence of yeasts 
stomatitis in vivo,14 although no significant reduction of yeast concentrations were observed. 
Apparently prevention of oral infection with yeasts is more related to a reduction of intrinsic 
pathogenicity than to a reduction of colonizing yeasts.26 
Criteria for disinfecting agents to be useful for oral flora suppression are:27 (1) the spectrum 
as assessed by MBC values; (2) the antimicrobials should be nonabsorbable to attain intralumi­
nal concentrations as high as possible; and (3) they should not be or only minimally inactivated 
by saliva, food compounds, fibre and enzymes. Apart from these three antimicrobial agent­
related factors, there are two host-related conditions that may be crucial in obtaining antimicro­
bially active salivary concentrations: (4) the dilution by oral secretions28•29 and (5) the contact 
time.3° Following the rapid turnover of saliva approximately 30% of the total chlorhexidine is 
reported to be retained in the mouth immediately following rinsing. This concentration was 
measured using 14C-chlorhexidine.28 Whether this 30% concentration was still antimicrobio­
logically active was not determined. According to Johnston and Bodey, rinsing does not 
guarantee a proper contact between antimicrobial agent and oral micro-organisms. 30 Taking into 
consideration the MBC increase for all microbes in saliva and secondly, the short contact time 
after rinsing, the logical step to enhance the effect of oral flora suppression by chlorhexidine 
would be the application of higher disinfecting concentrations in a pharmaceutical technological 
application form, such as gel, paste or lozenge, guaranteeing a sufficiently long contact time. A 
1 % chlorhexidine gel was applied in volunteers to reduce plaque formation and a profound 
influence on the oropharyngeal flora was observed.31 Whether this gel form with 1 % 
chlorhexidine may be of clinical value in patients suffering mucosa! lesions by e.g. irradiation 
is questionable because of the harmful side effects described in case of higher concentrations 
of chlorhexidine.32-34 
Chlorhexidine inactivation by saliva is shown to be an important factor that might contribute 
to the failure in oral flora suppression with chlorhexidine rinsing in irradiated patients. However, 
this cannot be the only mechanism because in irradiated head and neck cancer patients the 
amount and composition of saliva is changed. This need further investigation. 
In conclusion, the findings of this study explain why oral indigenous and 'community' micro­
organisms are controlled and 'hospital' acquired Gram-negative bacilli are not affected by 
chlorhexidine rinsing. For successful oral flora suppression in irradiated patients more potent 
antimicrobial agents should be used that are less inactivated by saliva and which should be 
applied in a gel, paste or lozenge form to guarantee a sufficient long contact time. 
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ABS1RACT 
Oral mucositis is one of the side-effects of irradiation in head and neck cancer patients. 
Chlorhexidine rinses are advised to relieve this side-effect The purpose of this prospective, 
randomized, placebo controlled, double blind study was to evaluate the effect of chlorhexidine 
0.1 % mouth rinses on irradiation mucositis. Thirthy (two groups of fifteen) patients with 
comparable irradiation treatment plans were studied by thrice weekly mucositis evaluation 
(mucositis score) during their five week course of conventional radiotherapy. Fifteen patients 
received an oral hygiene protocol with chlorhexidine 0.1 %. The other fifteen patients were 
treated with a placebo solution. No differences were found between both groups. Twelve 
patients developed pseudomembranes in each group after a mean of 18.8 days (s.d. 5.3) in the 
placebo group and 15.3 days (s.d. 2. 7) in the chlorhexidine group. Ulcerations were not observed 
in any study group. The highest mucositis score was 9 .3 (s.d. 1.4) and 9. l (s.d. 3 .5) respectively. 
Mycologically proven yeast stomatitis of the mouth was seen in two control patients only. The 
results of this study supports the hypothesis that mucositis is primarily a tissue reaction due to 
radiation. 
IN1RODUCTION 
Irradiation mucositis is defined as the reactive inflammatory-like changes of the oral mucosa 
following irradiation. Clinically four stages are distinguishable: (1) white discoloration, (2) 
erythema, (3) pseudomembranes, (4) ulcerations. Basically mucositis is a tissue reaction 
characterized by inflammation and necrosis and therefore seems to be an inevitable side-effect 
of irradiation treatment 1 
Oral hygiene programmes are commonly advised to prevent or reduce patient discomfort 
associated with irradiation mucositis. Mouth rinses are prescribed mainly for two reasons: (1) 
mechanical cleansing of the mouth to clear necrotic tissue and debris, 2 and (2) to prevent oral 
infections.3 Bemhoft and Skaug3 suggest that chlorhexidine rinsing may prevent or reduce 
mucositis caused by irradiation. Oropharyngeal flora is thought to play a role in irradiation 
mucositis. 
To our knowledge, no controlled studies on the effect of chlorhexidine 0.1 % rinsing on 
irradiation mucositis are available. Hence, we initiated a prospective, randomized, placebo 
controlled, double blind study to evaluate whether or not chlorhexidine 0.1 % mouth rinses 
influence irradiation mucositis. 
MATERIALS and METHODS 
Scoring mucositis. Mucositis was evaluated using qualitative and quantitative parameters. Four 
different local signs of mucositis might be distinguished: I = white discoloration, the white 
appearance of oral mucosa; 2 = erythema, defined as redness more pronounced than the red 
colour of non-irradiated normal mucosa; 3 = formation of pseudomembranes, i.e. white or 
yellow mucous plaques which are difficult to detach; 4 = ulceration, defined as the local 
complete loss of the mucosal layer. Mucositis of the oral cavity was determined for maximally 
eight (n = 8) distinguishable irradiated areas of the mouth: buccal mucosa (left & right), soft and 
hard palate, dorsum and border of the tongue (left & right) and the mouth floor. An area (the i-th 
area; i = l , ... n) might include several subareas dependent on the different local signs of mucositis 
observed in that particular area. The degree of m ucositis for each subarea was scored by the value 
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k on an ordinal scale (table 1). In one particular area there might be several subareas with an 
identical local sign of mucositis. The length of each subarea was measured by a modified pocket 
gauge (gauge of 2 cm), which was handy to use in the oral cavity, more particular in the more 
inaccessible areas, e.g. the mouth floor. The lengths of all subareas of identical local sign in one 
particular area were summed. The lenght (sum of lenghts) of subareas corresponded with a value 
E on an ordinal scale (table 1). The degree of mucositis of a subarea was defined as the product 
of the values k and E. The mucositis score of an area was defined as the sum of these products. 
Finally, the mucositis score a was defined as the mean of the scores assigned to n irradiated 
areas; the formula of the mucositis score a is as follows: 
n 4 




The mucositis score a is a combination of ordinal scale assessments. The choice of the scores 
is subjective, inevitably. Despite the arbitrariness involved one might expect that a higher score 
a corresponded with a clinically more severe condition.4 
Table 1: The indices for the local mucositis signs and the indices for the length of the mucositis signs as 
used in the mucositis score a. 
Local sign k Length E 
No mucositis 0 
White discoloration 1 � l cm 1 
Erythema 2 1 -2 cm 2 
Pseudomembranes 3 24 cm 3 
Ulceration 4 > 4 cm 4 
Yeast stomatitis. This is defined as an acute infection of the mucous membranes of the oral 
cavity. The most common symptoms of yeast stomatitis are burning sensation, tenderness and 
dryness. Clinically yeast stomatitis may present itself as superficial strand-like or drop-like 
growths that become confluent and form pearly-white elevated patches that resemble milk 
curds; or as a deep red erosion of the oral mucosa and patchy depapillation of the dorsum of the 
tongue, with minimal evidence of white lesions.5 Yeast stomatitis is mostly associated with 
� 105 colony forming units of yeast cells per ml of saliva.6 
Evaluation of generalized side effects. Local mucositis signs may be that severe that the 
patient may suffer pain in chewing, swallowing, speech and eating. These complaints may 
interfere with the feeding of the patient. Weight loss is an objective criterium and reflects best 
a real feeding problem.7 The only criterium for generalized side effects used in this study was 
weight loss, leading to the need of nasogastric tube feedings, defined as a loss of more than 1 kg 
per week. 
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Patients. From all the patients participating in this study informed consent was obtained. For all 
head and neck cancer patients in this study the irradiation procedures, i.e. field size of irradiation 
(volume), fractionation (2 Gy daily/five times weekly), irradiation source (Co60) and techniques 
(bilateral irradiation), were identical up to a total midline dose of at least 50 Gy (5 weeks). The 
irradiated tissue volumes in all patients were such that the major salivary glands (parotid and 
submandibular) were included. 
Surgery was performed on most of the patients before irradiation, either by radical resection 
or debulking of the primary tumor. Dental examination preceded the course of radiotherapy. 
Dental treatment deemed necessary to eliminate foci of infection or mechanical irritation, was 
performed as required, including provisional restoration of gross decay, removal of calculus 
deposits, smoothing of sharp restorations or cusps, endodontic treatment of non vital teeth and 
elimination of periapical or periodontal infections. Dentate patients applied daily a neutral 
fluoride gel with custom made trays, whereas edentulous patients were not allowed to wear their 
prostheses during the course of radiotherapy and three months thereafter. 
Study design. Thirthy patients were studied in a prospective, double blind, randomized, 
placebo controlled design. Fifteen patients received an oral hygiene programme with 
chlorhexidine 0.1 %. The other fifteen patients were treated with a placebo solution containing 
0.015% quininechloride to mimic the taste of chlorhexidine. Both solutions contained identical 
flavouring agents to correct the unpleasant taste. 
In all patients the oral cavity was sprayed daily with chlorhexidine 0.1 % or placebo during 
the course of irradiation. Further the patients rinsed their mouths by themselves as well during 
one minute, three times a day. The amount of sprayed and rinsed fluid was about 100 ml per day 
(spraying with 50 ml and three times rinsing with 15 ml). 
Statistical analysis. For comparison of the mucositis score in both study groups the randomi­
zation version of the Student-t test was used (at 5%, two-sided).8 
RESULTS 
Thirty patients entered the study. Tables 2a and b show the patients characteristics. No 
significant differences were observed in age, sex, type of neoplasm, prior surgery and irradiation 
programme. Table 3 and 4 depict the clinical data of the two patient groups during the five weeks 
of irradiation protocol. The first sign of mucositis were distinguished from the most severe 
mucositis stage (table 3 a,b/4 a,b). The first mucositis symptom was mostly erythema in both 
groups and was seen within 8.6 days (s.d. 2.1 )  in the placebo group and 8.9 days (s.d. 2.8) in the 
chlorhexidine group respectively. In both groups twelve patients developed pseudomembranes: 
after a mean of 18.8 days (s.d. 5.3) (26.7 Gy, s.d. 7.1 Gy) in the placebo group and of 15.3 days 
(s.d. 2. 7) (21.8 Gy, s.d. 2.9 Gy) in the chlorhexidine group. Ulcerations were not observed in any 
patient. 
The highest mucositis score, yeast stomatitis and severe generalized complaints are summa­
rized in table 3c/4c. The highest mucositis score was 9.3 (s.d. 1.4) at day 28 (s.d. 5.3) at a dose 
of 38.5 Gy (s.d. 7.5) for the placebo group, whereas the score was 9.1 (s.d. 3.5) at day 21.5 (s.d. 
5.1 )  at a dose of 31 .6 Gy (s.d. 7 .9) for the chlorhexidine group. Candida stomatitis (microbio­
logically confirmed) was seen in two control patients, on day 22 (30 Gy) and day 36 (50 Gy). 
Five patients (33%) using placebo mouth rinses needed nasogastric tube feedings because of 
weight loss after a mean of25 days (range 19-33 days), whereas three patients (20%) out of the 
chlorhexidine group were artifically fed for the same reason after a mean period of20 days (15-
23 days). 
Figure 1 shows the relation between the mucositis score a and the irradiation period in the two 
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Tabel 2 a: Patient characteristics of the patients (5 female, 10 male) treated with placebo rinsing. The mean 
age was 54.1 years, whereas 12 out of 15 underwent surgery before irradiation. 
patient age sex type neoplasm* surgery irrad. dose (Gy) 
1 43 f sec yes 50 
2 44 m ac yes 66 
3 66 m sec yes 66 
4 87 f sec yes 66 
5 65 m sec yes 66 
6 65 f sec no 66 
7 33 f ac yes 66 
8 60 m sec yes 66 
9 43 m sec yes 66 
10 55 f nhl no 50 
1 1  65 m sec yes 66 
12 40 m sec yes 66 
13 48 m nhl no 50 
14 56 m sec yes 68 
15 42 m sec yes 66 
mean f :  m yes : no 
54.1 1 :  3 12 : 3 
* sec = squamous cell carcinoma 
ac = adenocarcinoma 
nhl = non Hodgkin lymphoma 
Tabel 2 b: Patient data of the patients (6 female, 9 male) treated with chlorhexidine 0.1 % rinsing. The mean 
age was 61.9 years, whereas 13 patients underwent surgery before the onset of irradiation. 
patient age sex type neoplasm* surgery irrad. dose (Gy) 
16  77 f sec yes 70 
17 42 f ac yes 66 
18 85 f sec yes 68 
19 71 f sec yes 66 
20 70 m ac yes 66 
21 40 m sec yes 66 
22 61 m sec yes 66 
23 49 m sec yes 66 
24 76 m mfh yes 66 
25 50 f sec no 66 
26 55 m sec yes 66 
27 72 m sec yes 66 
28 67 f sec yes 66 
29 59 m sec no 66 
30 54 m sec yes 66 
mean f :  m yes : no 
61.9 2 :  3 13 : 2 
* sec = squamous cell carcinoma 
ac = adenocarcinoma 
mfh = malignant fibrous histiocytoma 
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Table 3 a: First sign of mucositis in the placebo rinsing group. 
patient sign time (day) dosis (Gy) a 
1 White discolor. 7 10 0.3 
2 Erythema 1 1  12 1.7 
3 White discolor. 9 14 0.4 
4 Erythema 6 8 2.6 
5 Erythema 12 18 1 . 1  
6 Erythema 7 10 1 .3 
7 Erythema 7 10 2.3 
8 Erythema 7 10 1 .1  
9 Erythema 10 16 3.9 
10 Erythema 10 16 1 .3 
1 1  Erythema 13 16 3.2 
12 Erythema 8 10 2.0 
13 Erythema 8 10 1 . 1  
14 Erythema 7 10 2.3 
15 Erythema 7 10 1.7 
Mean 8.6 12.0 1.8 
s.d. 2. 1 3.0 1.0 
Table 3 b: Most severe mucositis sign of the placebo treated patient group. 
patient sign time (day) dosis (Gy) a 
1 Pseudomembranes 16 22 2.6 
2 Pseudomembranes 20 26 6.3 
3 Pseudomembranes 16 24 5.6 
4 Pseudomembranes 17 24 8.3 
5 Pseudomembranes 33 44 7.3 
6 Erythema 7 10 1 .3 
7 Pseudo membranes 16 24 5.0 
8 Pseudomembranes 21 30 8.3 
9 Pseudomembranes 17 26 6.1 
10 Pseudomembranes 24 36 4.0 
1 1  Erythema 13 16 3.2 
12 Erythema 8 10 2.0 
13 Pseudomembranes 19 28 4.2 
14 Pseudomembranes 14 20 3.9 
15 Pseudomembranes 12 16 5.6 
Mean 16.9 23.7 4.9 
s.d. 6.2 8.7 2.1 
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Table 3 c: Highestmucositis score and generalized symptoms in the placebo treated patients. Alimentation 
problems/weight loss was seen in five of the patients, whereas two patients developed yeast 
stomatitis. 
patient sign time (day) dosis (Gy) a Symptoms 
1 Pseudomembranes 33 44 1 1 .5 Alimentation problems/weight loss 
(tube feeding day 33/44 Gy) 
2 Pseudomembranes 22 30 9.7 Candida stomatitis day 22/30 Gy 
Alimentation problems/weight loss 
(tube feeding day 20/26 Gy) 
3 Pseudomembranes 21 30 9.0 
4 Pseudomembranes 30 38 10.4 Alimentation problems/weight loss 
(tube feeding day 33/44 Gy) 
5 Pseudomembranes 33 44 7.3 
6 Erythema 23 28 8.0 
7 Pseudomembranes 19 26 9.7 Alimentation problems/weight loss 
(tube feeding day 20/28 Gy) 
8 Pseudomembranes 30 44 10.3 
9 Pseudomembranes 22 32 10.1 Candida stomatitis (day 36/50 Gy) 
10 Pseudomembranes 31 46 7.0 
1 1  Erythema 24 34 9.6 
12 Erythema 37 50 10.0 
13 Pseudomembranes 26 38 6.4 
14 Pseudomembranes 33 46 8.9 Severe xerostomia 
15 Pseudomembranes 33 46 11 .0 Alimentation problems/weight loss 
(tube feeding day 19/26 Gy) 
Mean 28.0 38.5 9.3 
s.d. 5.3 7.5 1 .4 
patient groups. Between the onset of the second week and the end of the third week a steadily 
increased, reflecting a change from erythema into pseudomembranes in both groups. A plateau 
is established after the third week in the control group as well as in the chlorhexidine group. 
Weight loss, yeast stomatitis and the highest mucositis score occurred after three weeks in both 
placebo and chlorhexidine group. No significant difference in mucositis score was found 
between the two study groups over the five week period of irradiation. 
DISCUSSION 
The major result of this study was that chlorhexidine 0.1 % mouth rinsing did not reduce 
irradiation mucositis more successfully than placebo mouth rinsing. This observation supports 
the hypothesis that irradiation mucositis in head and neck cancer patients is merely a tissue 
reaction due to the trauma of irradiation.9 The dose-response curve is the major reason on which 
this concept is based.10 According to this philosophy potentially pathogenic micro-organisms 
play a secondary role in causing inflammatory reactions, e.g. yeast stomatitis. 
Radiotherapy is associated with disruptions in function and integrity of the mucosa.11 These 
changes through inhibition of cell growth and maturation, interrupt the mucosa) barrier of the 
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Table 4 a: First sign of mucositis in the chlorhexidine 0.1 % rinsing patients. 
patient sign time (day) dosis (Gy) a 
16  Erythema 7 10 0.6 
17 Erythema 14 1 6  1 .0 
18  Erythema 8 12 1 .4 
19  Erythema 9 14 0.9 
20 Erythema 9 12 1 . 1  
21  Erythema 6 10 1 . 1  
22 Erythema 5 8 1 . 1  
23 Erythema 8 12 0.6 
24 Erythema 14 20 3.4 
25 Erythema 12 20 1 .4 
26 Erythema 5 10 2.7 
27 White discolor. 8 12 0.3 
28 Erythema 12 16  1 .7 
29 Erythema 8 12 2.6 
30 Erythema 9 14 2.3 
Mean 8.9 13.2 1 .5 
s.d. 2.8 3.4 0.9 
Table 4 b: Most severe mucositis sign in the chlorhexidine 0.1 % rinsing patients. 
patient sign time (day) dosis (Gy) a 
16  Pseudomembranes 14 20 3.7 
17 Pseudomembranes 16 20 4.2 
18 Pseudomembranes 10 16 2.0 
19 Pseudomembranes 19 26 6.7 
20 Pseudomembranes 16  22 1 .9 
21 Pseudomembranes 13 20 6.7 
22 Erythema 5 8 1 . 1  
23 Pseudomembranes 12 20 4.1 
24 Pseudomembranes 19 26 6.3 
25 Pseudomembranes 15 22 5.0 
26 Erythema 5 10 2.7 
27 Pseudomembrancs 15 22 5 .0 
28 Pseudomembranes 19 26 9.7 
29 Pseudomembrancs 15 22 1 1 .4 
30 Erythema 9 14 2.3 
Mean 13.5 19.6 4.9 
s.d. 4.4 5.3 2.8 
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Table 4 c: Highest mucositis score and generalized symptoms in the chlorhexidine 0.1 % rinsing group. 
Three patients needed nasogastric tube feedings; no yeast stomatitis occurred. 
patient sign 
16 Pseudomembranes 
17  Pseudomembranes 
18  Pseudomembranes 
19 Pseudomembranes 
20 Pseudomembranes 
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mouth, promoting adherence and colonization by potentially pathogenic micro-organisms. Out 
of all potentially pathogenic micro-organisms colonizing the oral cavity, Candida species are 
well known to have the highest intrinsic pathogenicity.5•12 Two control patients developed a 
Candida stomatitis, while none of the patients rinsing with chlorhexidine 0.1 % suffered yeast 
stomatitis. This effective control of oral infection by yeasts is probably associated with a 
reduction of intrinsic pathogenicity (adherence),13•14 because chlorhexidine rinsing did not 
result in a significant reduction of yeast colonization. 
If oral micro-organisms may contribute to the severity of irradiation mucositis in head and 
neck cancer patients, it is very unlikely that the indigenous flora (viridans streptococci) plays 
any significant role. Chlorhexidine 0.1 % rinsing, however, significantly reduced this type of 
flora in that particular patient population, 15 whereas all mucositis stadia were seen. Chen et al. 
and Martin et al. showed that the severity of irradiation mucositis was not influenced by the 
absence or presence of Candida species.16•17 Chlorhexidine failed in decontaminating the 
oropharyngeal cavity from Gram-negative bacilli. These bacteria, even in low concentrations, 
are well known to be potent endotoxin producers whereas viridans streptococci and yeasts do 
not release endotoxin.18 Endotoxins are inflammation mediators.19.2° Considering this, it might 
be worthwhile to try to decontaminate the oropharynx specially from these endotoxin producing 
Gram-negative bacilli, in order to reduce the irradiation mucositis. A prospective study on this 
hypothesis is in progress. 
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ABS1RACT 
Recently is reported that chlorhexidine 0.1 % rinsing was not successful in eradication of Gram­
negative bacilli in patients who have head and neck cancer. These bacilli could play a role in 
irradiation mucositis. This study reports the effect of lozenges containing 2 mg polymyxin E 
(colistin), 1.8 mg tobramycin and 10 mg amphotericin B four times daily on the oropharyngeal 
flora in fifteen irradiated head and neck cancer patients. The results were compared with those 
of a previous study in two groups of fifteen patients comparing chlorhexidine rinsing with 
placebo. In all patients using lozenges eradication of Gram-negative bacilli and yeasts was 
achieved within three weeks. A significant increase of enterococci was found. 
Mucositis was significantly reduced compared with the previous two groups. All patients 
showed erythema only, whereas 80% of both the placebo and chlorhexidine rinsing patients 
suffered from severe mucositis, with signs of pseudomembranes developing from the third week 
of conventional irradiation protocol. 
The effect of selective elimination of Gram-negative bacilli from the oropharynx and the 
prevention of severe mucositis may be explained by the eradication of these bacteria and/or 
neutralization of salivary endotoxin, released by Gram-negative bacilli, mediating the inflam­
matory processes. These interesting observations require further research. 
IN1RODUCTION 
Mucositis induced by irradiation is defined as the reactive inflammatory-like process of the 
oropharyngeal mucosa following therapeutic irradiation of patients who have head and neck 
cancer. Irradiation mucositis is basically a tissue reaction.' Oral flora colonizing the mucous 
membranes is thought to aggravate mucositis.2 
Oral hygiene programmes are commonly advised to prevent or reduce discomfort associated 
with irradiation mucositis. Chlorhexidine mouth rinses are prescribed mainly for two reasons: 
(1) mechanical cleansing of the mouth to clear necrotic tissue and debris, 3 and (2) to prevent oral 
infections.2Ferretti et al.4, who investigated patients receiving bone marrow transplants, related 
these benificial effects of prophylactic chlorhexidine rinsing primarily to its sustained topical 
antimicrobial properties. In a previous study in irradiated head and neck cancer patients yeast 
stomatitis could effectively be controlled by chlorhexidine, but no reduction in mucositis was 
seen.5 During five weeks of chlorhexidine treatment no other changes were found except a 
significant reduction in viridans streptococci. Apparently the control of yeast stomatitis by 
chlorhexidine is not associated with a significant yeast suppression but rather with a reduction 
of the pathogenicity by interference with adherence.6•7 
Numerous studies suggest that yeast colonization is not involved in the pathogenesis of 
mucositis.8•11 Chen & Webster,8Martin et al.9, Pau et al. 10 and Elliott" consider the development 
of mucositis rather as a consequence of irradiation than as a consequence of yeast colonization, 
because the severity of acute radiation reactions was not influenced by the presence or absence 
of yeasts. Identical observations were reported for viridans streptococci.5•10 
In all chlorhexidine studies which included culturing of Gram-negative bacilli a high oral 
carriage of Gram-negative bacilli was found.2.s-12 Elliott studied control of yeast stomatitis by 
topical ketoconazole in these patients and confirmed these observations of carriage of Gram­
negative bacilli in the oral cavity." 
These observations prompted us to start a pilot study to investigate the effect of selective 
elimination of Gram-negative bacilli13 from the oral cavity on mucositis. These results are 
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compared with a previous study on the effect of chlorhexidine 0.1 % rinsing versus placebo 
rinsing on mucositis.5 
MATERIALS and METHODS 
Patients. Fifteen head and neck cancer patients who were radiated at the oropharyngeal areas 
were included in this study after obtaining informed consent. The patients received external 
bilateral irradiation via parallel opposed portals by an linear accelerator (4 MeV), 2 Gy daily, 
five times a week, a total dose of at least 50 Gy (midline dose). The irradiation portals were such 
that all major salivary glands (parotid and submandibular) were included. 
The policy outlined by the oncology team was based on a planned combined surgery­
irradiation approach in this group of patients. Radical resection or debulking of the primary 
tumor often preceded the irradiation course. 
All patients received a preradiotherapy dental examination and treatment to eliminate foci of 
infection or mechanical irritation. This included, provisional restoration of gross decay or 
extraction, removal of calculus deposits, smoothing of sharp restorations or cusps, and 
endodontic treatment of nonvital teeth. Edentulous patients were not allowed to wear their 
prostheses, 14•15 whilst dentate patients applied daily a neutral fluoride gel by means of custom 
made trays.16•17 
Study design. Fifteen consecutive head and neck cancer patients received lozenges of 1 gram 
containing a combination ofpolymyxin E (colistin) 2 mg and tobramycin 1.8 mg.18 Amphoter­
icin B 10 mg was added to prevent yeast stomatitis. The administration frequency was four times 
daily starting on the first day of irradiation for five consecutive weeks of conventional radiation 
protocol. In all patients the oral cavity was sprayed daily by an oral hygienist with a flavoured 
deionized water solution (without any inhibiting effect on bacteria) during the course of radio­
therapy. In this way all mouth areas were carefully cleansed. The patients were asked to rinse 
their mouths by themselves as well during 1 minute, three times a day with this rinsing solution. 
The amount of fluid sprayed and rinsed was about 100 ml per day (spraying 50 ml, rinsing three 
times 15 ml). 
Scoring and monitoring of mucositis. The mucositis was evaluated in a semi-quantitative 
way, starting on the first irradiation day and thrice weekly afterwards (Monday, Wednesday, 
Friday). The details of the scoring technique are described elsewhere.19 
Oropharyngealflora sampling. Before starting radiotherapy, the oral cavity of all patients 
was sampled twice by the gargling method using isotonic saline as the collecting fluid. During 
the irradiation course the sampling frequency was thrice weekly at the same days of mucositis 
scoring. The subject rinsed and gargled with IO ml of saline during 30 seconds and collected it 
in a sterile vial (Cordis Laboratories, Roden, The Netherlands). The samples were obtained 
between 8.00 and 9.00 a.m. on the sample days and processed quantitatively in the laboratory 
within one hour. 
Microbiological methods. One ml of the sample was added to 9 ml of brain heart infusion 
(BID) broth (Lab M, Salford, England), to make serial tenfold dilutions. Dilution series were 
made in trays of 64 (8x8) cups of 1.5 ml (Thovadec, Ede, The Netherlands). Each cup was filled 
with 0.45 ml of BHI. A 0.05 ml sample from the 1: 10 diluted oropharyngeal suspension was 
mixed with 0.45 ml BID in the first cup, resulting in a 1:100 oropharyngeal suspension. All 
dilution steps from I0-2 through 10-9 were prepared with 0.05 ml microdiluters (Dynatech AG, 
Zug, Switzerland). 
The oropharyngeal samples were incubated at 37°C for 18 hours. The number of cups 
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showing turbidity due to growth of bacteria indicates the logarithm of the concentration of 
micro-organisms per ml of oropharyngeal washing, i.e. quantitative detennination. Thereafter, 
all dilutions with growth were subcultured on MacConkey agar (Gibco Limited, Paisley, 
Scotland), yeast morphology agar (Merck, Darmstadt, West-Gennany), kanamycin aesculin 
(Lab M, Salford, England) and blood agar (Gibco Limited, Paisley, Scotland) for qualitative 
determination. Enterobacteriaceae, Pseudomonadaceae and Acinetobacter spp. were evalu­
ated on MacConkey agar, yeasts on yeast morphology agar, Efaecalis on kanamycin aesculin 
agar and streptococci and staphylococci on blood agar. Morphologically distinct colonies were 
isolated in pure culture. The identification was done by standard microbiological techniques.2() 
Definitions. Carriage of a particular micro-organism was defined as the condition in which a 
study patient showed a minimum of two consecutive oral washings positive for that micro­
organism. 
Colonization index of the oral cavity was defined as the sum of logarithms of the concentra­
tions of a particular micro-organism isolated from 1 ml of oral washing specimens divided by 
the number of oral washings. 
Analysis of results. The results of this prospective pilot study were compared with those of a 
previous placebo controlled study in thirty patients onto the effect of chlorhexidine 0.1 % rinsing 
on oropharyngeal ecology, recently published by our group.5 From data collected from the 
patients in each week of the study the mean colonization index and the percentage of carriage 
was calculated. Weekly means of these numbers for each of the three treatment groups were 
plotted in a graph. The results at the end of the study (week 5) were compared by means of the 
randomization version of the Student t-test, performed at 5% or less confidence limits, two­
sided.21 
Table 1: Patient data of the group using lozenges including polymyxin E, tobramycin and 
amphotericin B. 
patient age sex type neoplasm* surgery irrad. dose (Gy) 
31  52 f sec no 50 
32 37 m sec yes 66 
33 43 m sec yes 70 
34 72 m sec yes 70 
35 74 m sec yes 66 
36 48 m sec yes 66 
37 61  m sec yes 66 
38 5 1  f sec yes 70 
39 72 f sec no 66 
40 80 f sec yes 70 
41 57 m sec yes 70 
42 77 m sec yes 70 
43 46 m sec no 70 
44 83 m sec yes 66 
45 67 m sec yes 66 
mean f :  m yes: no 
61 .3 4 :  1 1  12 : 3 





Patients. Fifteen patients (table 1) participated in the study, four females and eleven males, mean 
age 61.3 (s.d. 14.2). Twelve patients were operated prior to irradiation. Eleven patients were 
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Microbiology. Figures 1 a and 1 b represent carriage and colonization index for viridans 
streptococci. No difference was seen between the patient group using lozenges and the placebo 
group. The colonization index was significantly reduced at week five in the chlorhexidine group 
only (p<0.05). 
Figures 2 a and 2 b depict S.epidermidis carriage and colonization index. The carriage rate 
and colonization index were significantly lower in the lozenge group than in the placebo group 
at the end of the study period (p<0.05). 
Figures 3 a and 3 b show the findings for S.aureus. The numbers of carriers and the oral 
concentrations were very small. Chlorhexidine seemed to have a slight effect: there was one 
carrier in both the lozenge and placebo group and none in the chlorhexidine group. 
Figures 4 a and 4 b show the Efaecalis results. In each group two patients carried Efaecalis 
before the trial. Also the colonization index of the oral cavity for Efaecalis was low in each 
viridan1 1treptococci (carriage) 
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Figure 1 a: 
Carriage of the oropharymc for viridans strepto­
cocci in the three study groups using placebo, 
chlorhexidine 0.1 % rinses and PT A-lozenges re­
spectively during conventional irradiation proto­
col. No difference was seen between the three 
patient groups. 
(PT A =polymyxin E, tobramycin, amphotericinB) 
Figure 1 b: 
Colonization index of the oropharynx for viridans 
streptococci in the three patient groups. The colon­
ization index was significantly reduced at week 
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Figure 2 a: 
Carriage of the oropharynx for S.epidermidis in the 
groups using placebo, chlorhexidine 0.1 % rinses 
and PTA-lozenges during radiation therapy. 
The carriage rate was significantly lower in the 
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Figure 2 b: 
Colonization index of the oropharynx for 
S.epidermidis. 
The colonization index was significantly lower in 
the group using PT A-lozenges than in the placebo 













$.aureua Ccalomzation index) 
a • ==::::::'.,=-2- � 
a I 2 3 
placebo n = I 5 
4 5 
T Cweelu) 
.......... chlorhexid1ne n . I 5 
PT A lozenge n = I 5 
Figure 3 a: 
Carriage of the oropharynx for S.aureus was small 
in the three groups using placebo, chlorhexidine 
0.1 % rinses and PT A-lozenges during conven­
tional irradiation protocol. 
Chlorhexidine seemed to have a slight effect. 
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Figure 3 b: 
Colonization index of the oropharynx for S.aureus. 
No difference in either of the groups using placebo, 
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Figure 4 a: 
Carriage of the oropharynx for Efaecalis in the 
groups using placebo, chlorhexidine 0.1 % rinses 
and PTA-lozenges during radiation therapy. 
After five weeks of lozenges the carriage was 
significantly increased compared to both placebo 
and chlorhexidine 0.1 % rinsing groups (p<0.01). 
This level of significance was already reached after 
two weeks. 
Figure 4 b: 
Colonization index of the oropharynx for 
Ef aecalis in the three study groups. 
The colonization index in the group using PT A­
lozenges was significantly increased at the fifth 
week compared to placebo and chlorhexidine 0.1 % 
rinsing groups (p<0.01). 
group. After five weeks of lozenges both carriage and colonization index were significantly 
increased compared to the placebo and chlorhexidine group (p<0.01). This was observed 
already after two weeks of lozenge treatment Nine patients (60%) carried E faecalis in the oral 
cavity in a mean concentration of 102 colony forming units per ml of saliva at the end of the 
irradiation course of five weeks. 
Figures 5 a and 5 b represent Candida species carriage and colonization index. Base line oral 
Yeasts (carriage) 
0-0 placebo n • I 5 
........., chlorhe xidine n = I 5 
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Figure 5 a: 
Carriage of the oropharynx for Candida species in 
the three study arms, placebo, chlorhexidine 0.1 % 
rinses and PT A-lozenges. After five weeks ofusing 
PTA-lozenges a significant reduction of carriage 
was observed compared to both placebo and chlor­
hexidine 0.1 % rinses treatment (p<0.01); this level 













Figure 5 b: 
Ytuta (colonization index) 
3 4 5 
T (weeks) 
Colonization index of the oropharynx for Candida 
species. 
The colonization index was significantly reduced 
after five weeks of using PT A-lozenges compared 






washings revealed a carriage rate of about 20%. After two weeks of lozenges a significant 
reduction of both carriage and colonization index was found compared to both placebo and 
chlorhexidine treatment. Yeast stomatitis was successfully controlled in both amphotericin B 
and chlorhexidine group, whereas two placebo patients suffered Candida stomatitis at day 22 
and day 36, respectively. The effective control of yeast stomatitis was associated with a 
significant reduction of carriage (p<0.01) and colonization index (p<0.05) obtained in the group 
using lozenges but not in the chlorhexidine group. 
Figures 6 a and 6 b depict carriage and colonization index of Enterobacteriaceae, 
Pseudomonadaceae andAcinetobacter species. More than half of the patients were oral carriers 
of Gram-negative bacilli on admission. The colonization index was about 1. The use of lozenges 
resulted in a significant reduction of carriage (p<0.01) and colonization index (p<0.05) at week 
5 compared to both placebo and chlorhexidine rinsing groups. This was observed already after 
two weeks of treatment and for the rest of the irradiation course. 
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Figure 6 a: 
Carriage of the oropharynx for Enterobacteri­
aceae, Pseudorru:madaceae and Acinetobacter 
species. 
The carriage was about 50% in the patients before 
onset of the therapy in the three study groups. The 
use of PT A-lozenges resulted in a significant re­
duction of carriage at week five compared to both 
placebo and chlorhexidine 0.1 % rinsing groups 
(p<0.01). This level was already reached after two 
weeks. 
Figure 6 b: 
Colonization index of the oropharynx for Entero­
bacteriaceae, Pseudomonadaceae and Acineto­
bacter species. 
The index was significantly reduced in the group 
using PT A-lozenges at week five compared to both 
placebo and chlorhexidine 0.1 % rinsing groups 
(p<0.05). This level was already reached after two 
weeks. 
Scoring mucositis. The mucositis was significantly reduced after three weeks of lozenges, 
compared with the two other groups studied (p<0.05). Clinically the patients only showed 
erythema even after a therapeutic dose of irradiation of 50 Gy. Pseudomembrane formation was 
completely prevented, whereas 80% of the placebo andchlorhexidine patients suffered from this 
severe form of mucositis (p<0.O 1 ). Moreover, no patient needed nasogastric tube feedings while 
eight patients out of the thirthy placebo and chlorhexidine patients were artifically fed after the 
third week of irradiation because of mucositis (p<0.05). 
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DISCUSSION 
Four major findings emerged from this study that require comments. (1) Successful elimination 
of oral Gram-negative bacilli was obtained using lozenges including polymyxin E, tobramycin 
and amphotericin B. (2) The use of the lozenges was associated with a significant increase of 
oral enterococci. (3) Yeast stomatitis was successfully prevented by the lozenges. (4) Severe 
mucosi tis (pseudomem branes) and generalized complications such as nasogastric tube feedings 
and weight loss, seemed to be prevented by elimination of oral Gram-negative bacilli. 
The successful elimination of oral Gram-negative bacilli using lozenges may be explained 
by the choice of the antibiotic combination and the pharmaceutical technological form.18 The 
combination of polymyxin E and tobramycin covers all Enterobacteriaceae, Pseudo­
monadaceae and Acinetobacter species. Both antibiotics are non-absorbable and bactericidal. 
Synergism and addition is known forpolymyxin E and tobramycin. Although this antimicrobial 
combination has been shown to be inactivated by saliva, the amount of polymyxin E and 
tobramycin needed to kill Gram-negative bacilli in saliva is 20 to 40 times less than the 
concentrations applied with these lozenges.22 Besides spectrum, mode of action, pharmacokin­
etics, salivary inactivation and synergism/addition, a longer and proper contact time between 
colonizing Gram-negative bacilli and antimicrobials is guaranteed by lozenges. The persistent 
oral carriage of Gram-negative bacilli in the chlorhexidine rinsing studies may be explained by 
the high inactivation rate of chlorhexidine by saliva23 and the short contact time during 
rinsing.7A,7.5 
The successful elimination of oral Gram-negative bacilli by lozenges confirms the results of 
other oral decontamination studies in intensive care unit patients who received a paste with 2% 
polymyxin E, tobramycin and amphotericin B also guaranteeing a sufficient long contact 
time.26---29 Whereas in ICU patients the elimination of oral Gram-negative bacilli took less than 
five days, in our study the period needed to decontaminate all fifteen patients was more than two 
weeks. There are a number of differences between ICU patients and irradiated head and neck 
cancer patients. Firstly, most of the cancer patients underwent surgery of the oral cavity before 
the onset of irradiation and application of lozenges. Surgery may be associated with intraoral 
lesions, not yet completely healed, and/or necrotic tissue of a partially debulked oral tumor. 
Integrity of anatomy is a prerequisite for elimination of Gram-negative bacilli. Secondly, most 
ICU patients were unconscious allowing a proper application of the sticky paste. The patients 
who have head and neck cancer sucked their lozenges four times daily and ate normal 
unsterilized food. 
Oral enterococcal carriage in healthy individuals is less than 10%.30 Whether the significant 
increase of enterococci from 13% into 60% is caused either by elimination of yeasts and/or 
Gram-negative bacilli or by disturbance of the indigenous flora by the antimicrobials used can­
not be answered with this pilot study. The clinical implication concerning mucositis of this flora 
shift seems to be minimal, because pseudomembranes were successfully prevented in the 
presence of oral enterococci. 
Both rinsing with chlorhexidine and the use of lozenges effectively prevented yeast 
stomatitis. Complete eradication of yeast colonization was not achieved in either of the 
treatments, although significant reduction by amphotericin B lozenges was observed. These 
observations suggest another pathogenic mechanism for oral infection by yeasts than growth 
density only, e.g. adherence to the mucosa.31 Chlorhexidine might be effective in reducing the 
adherence of yeast species to mucosal cells.6•7 
The most striking result of this pilot study was the prevention of the severe form of m ucosi tis, 
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i.e. the formation of pseudomembranes in all patients. None of the patients required nasogastric 
tube feedings, reflecting the efficacy of the prevention of severe local mucositis. A similar 
observation is reported by Rosoff who showed that rats rendered 'coliform-negative' with 
polymyxin could tolerate higher doses of radiation than rats that received the same antimicrobial 
but remained 'coliform-positive' .32 
It is postulated that Gram-negative bacilli or endotoxin released by Gram-negative bacilli33 
may play an important role in the pathogenesis of mucositis during irradiation, more particular 
in the development of pseudomembranes. Endotoxin is known to be a potent inflammation 
mediator.34 Polymyxin E (colistin) may be responsible for an effective endotoxin neutraliza­
tion35·36 and hence for prevention of pseudomembrane formation. To elucidate this working 
hypothesis, the salivary endotoxin in the three study groups will be measured. This laboratory 
work is now in progress. 
Since this study has been designed as a pilot study and the number of patients is small, 
confirmation of these results is required in a larger multicenter study with proper controls. 
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ABS1RACT 
Eradication of oral Gram-negative bacillary carriage has been described in patients with head 
and neck cancer who have irradiation mucositis using lozenges containing 2 mg of polymyxin 
E (colistin) and 1.8 mg of tobramycin. Salivary concentrations of antimicrobials lethal for 
Gram-negative bacilli colonizing the oropharynx are thought to be crucialin the outcome oforal 
flora elimination procedures. Amongst the factors determining these bactericidal concentra­
tions to be achieved in saliva, the degree of inactivation of the antimicrobials by salivary proteins 
is an important criterium. To evaluate the role of salivary inactivation of polymyxin E (colistin) 
and tobramycin, minimum bactericidal concentration (MBC) values of these two antimicrobials 
(separately and in combination) were studied for eight different Gram-negative bacilli (80 
isolates) using a standard dilution method in fresh whole saliva, broth and glucose 5%. The lethal 
action of tobramycin was significantly reduced by saliva and broth for all isolates as compared 
to glucose 5%. Identical results were found for colistin for all but Enterobacter and Klebsiella 
species. Both saliva and broth had a significantly reducing impact on the bactericidal action of 
the combined antimicrobials for all isolates. Synergism was found for Citrobacter, Proteus, 
Serratia, Pseudomonas and Acinetobacter species, while the combined antimicrobials were 
additive against Escherichia coli, Klebsiella and Enterobacter species in all media. The range 
of the median MBC values of combined polymyxin E and tobramycin for all Gram-negative 
bacilli tested in fresh whole saliva were 2.1-9.0 mg/I and 1.7-7.4 mg/I respectively. The lozenges 
used in the clinical study were calculated to achieve salivary concentrations that correspond with 
100 mg/I of polymyxin E and 90 mg/I of tobramycin, i.e. about IO times the highest MBC's of 
the two antimicrobials for all isolates tested in this salivary inactivation study. These high lethal 
salivary concentrations guarantee an overkill to overcome person-to-person variations and may 
contribute to the successful eradication of oral Gram-negative bacillary carriage observed in the 
clinical trial. 
INTRODUCTION 
Recent studies on oral flora elimination in patients with head and neck cancer who have 
irradiation mucositis show that chlorhexidine rinsing failed in eradicating oral Gram-negative 
bacillary carriage, 1.2 whilst a complete eradication had been achieved by the use of lozenges 
containing polymyxin E and tobramycin.3 Salivary concentrations of antimicrobials lethal for 
Gram-negative bacilli colonizing the oropharynx are considered to be crucial in the outcome of 
oral flora elimination techniques. Amongst the factors determining these bactericidal concen­
trations to be achieved in saliva, the degree of inactiviation of antimicrobials by salivary proteins 
is thought to be an important criterium. Chlorhexidine is reported to be strongly inactivated by 
fresh whole saliva.4 This reduction of lethal activity of chlorhexidine for all Gram-negative 
bacilli tested in saliva is shown to have contributed to the failures of eradication of oral Gram­
negative bacillary carriage. To evaluate the role of salivary inactivations of polymyxin E 
(colistin) and tobramycin in the outcome of oral flora elimination, an in vitro study was 
undertaken to investigate the influence of saliva on these two antimicrobials. 
MA IBRIALS and METHODS 
Saliva. Fresh stimulated whole saliva from one and the same healthy person was obtained at the 
same time at each test day (between 9.00-10.00 a.m.). The saliva was obtained by chewing 
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parafilm and collected in a sterile vial. The volunteer did not carry Enterobacteriaceae, 
Pseudomonadaceae and Acinetobacter species neither yeasts. One ml of saliva contained only 
indigenous oral flora, i.e. 106 colony forming units (CFU) of viridans streptococci (106 
Streptococcus salivarius, 104 Streptococcus mutans) and 108 anaerobic species (108 total 
streptococci, 106 Veillonel/a spp., 105 Actinomyces spp.). Table 1 depicts the sialochemistry 
findings of the saliva used. 
Table 1 :  Sialochemistry values in the healthy volunteer of the used saliva samples in the inactivation 
experiments. 
average s.d. 
Sodium mmol/1 5.7 1 .4 
Potassium mmol/1 22.3 0.5 
Calcium mmol/1 0.92 0.05 
Chloride mmol/1 10.3 1 .4 
Phosphate mmol/1 4.62 0.19  
Urea mmol/1 4.5 0.7 
Amylase g/1 0.24 0.07 
Total protein g/1 1 .55 0.26 
Broth. Susceptibility testing was performed according to standardized broth dilution pro­
cedure.5·6 Trypticase soy broth (TSB, Oxoid LTD, Basingstoke, England) was used in two 
concentrations 100% and 50% diluted with fresh whole saliva, i.e. TSB diluted with the same 
amount of saliva. 
Control solution. As protein free solution glucose 5% was used, being a normal component 
of fresh whole saliva. 
Antimicrobial agents. The antimicrobial agents tested were: (1) polymyxin E sulphate 
(Dumex, Hilversum, The Netherlands) and; (2) tobramycin sulphate (Eli Lilly, Nieuwegein, 
The Netherlands). In addition the combination of polymyxin E and tobramycin was tested. 
Micro-organisms. Ten different strains of eight different types of Gram-negative bacilli were 
tested, including Escherichia coli, Klebsiella, Proteus, Enterobacter, Pseudomonas, Serratia, 
Acinetobacter and Citrobacter species. All eighty strains were obtained from clinical specimens 
processed in the Department of Oral Microbiology of the University Hospital Groningen, The 
Netherlands and the Royal Liverpool Childrens Hospital Alder Hey, Liverpool, United 
Kingdom. An overnight culture (109 CFU per ml) was obtained by inoculation of the test strain 
in 9 ml brain heart infusion (BHI) broth (Lab M, Salford, England) and incubation for 18 hours 
at 37°C. The overnight cultures were centrifuged at 3000 rpm for 5 minutes. After decanting the 
supernatant, the pellet was resuspended in deionized water and diluted to a concentration of 106 
CFU per ml. Using this concentration, four suspensions of 105 CFU/ml of the test micro­
organism were made by adding I ml to 9 ml of glucose 5%, of TSB, of 50% TSB in 50% saliva 
and of fresh whole saliva, respectively. 
Testing activity of antimicrobial agents by means of MBC. The activity of the antibacterial 
agents was determined by means of the MBC, the minimum concentration of the drug required 
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to accomplish irreversible inhibition, i.e. killing after subculturing on solid media. The MBC of 
the antimicrobial agents was detennined in four different suspensions for 10 different strains of 
the eight different types of micro-organisms used. The experiment was carried out in the course 
of 48 test days. On each day enough stimulated fresh saliva was collected from the same healthy 
volunteer. On each test day five strains of one type of micro-organism could be tested for one 
type of the antimicrobial agents in the four different suspensions. In these techniques a tray (see 
figure 1) with 64 (8x8) cups of 1.5 ml was used (Thovadec, Ede, The Netherlands). Half a tray 
was used for testing antimicrobial activity against one test micro-organism in the presence of 
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Figure 1 :  
Determination of  MBC's using the tray method. The antimicrobial (polymyxin E, tobramycin or the 
combination) was added to cup Al .  Two-fold dilution steps were made into both directions from the left 
to the right and from the top downward, resulting in identical concentrations along slopes (e.g. A8-D5). 
one of the four suspensions. The first row of the tray (i.e. Al-D1) was filled with 0.45 ml of the 
bacterial suspension except cup A l .  All four cups of the other rows (from row A2-D2 to A8-
D8)were filled with 0.225 ml of the identical bacterial suspension. Cup Al  was filled with 
0.95 ml of the bacterial suspension to which 0.05 ml of one of the antimicrobial agents was 
added. The concentration of antimicrobial agents which were added was 3200 mg/I for both 
colistin and tobramycin. Cup Al contained a total of 1 ml of suspension with 160 mg/I colistin 
or 160 mg/I tobramycin. With a Finnpipette (Lamers & Pluyer, 's-Hertogenbosch, The Nether­
lands) 2-fold dilution steps (0.45 ml) were made from Al to D1. Starting with a concentration 
of 160 mg/I of e.g. colistin, a concentration of 20 mg/I was obtained in this way in cup DI .  
Analogously, with a W.H.O. 4-channel pipette (Amstelstadt, Amsterdam, The Netherlands) 
2-fold dilution steps (0.225 ml) were made from Al to A8; from Bl  to B8; from Cl to C8 and 
from D 1 to D8. This results in a concentration of 1.3 mg/I in cup A8 and 0.2 mg/I in cup D8. 
In this way identical concentrations of the tested antimicrobial agent were reached along 
slopes from e.g. cup A8 to D5. Using this method two trays were needed for testing each of the 
antimicrobial agents against one micro-organism in glucose 5%, TSB, 50% saliva in TSB and 
in whole saliva. The trays were incubated for 18 hours at 37°C. After incubation all trays were 
subcultured on MacConkey agar (Gibco Limited, Paisley, Scotland). The first slope which 
showed no colony growth gave the MBC of the antimicrobial agent tested for that micro-
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organism. In order to exclude a possible cidal effect of the four different media, all tests were 
controlled by subculturing the test strains without antimicrobial agent for 18 hours at 37°C. The 
dilution series were subcultured on the above mentioned solid media. 
Definitions. Addition is defined as these antimicrobial interactions whereby the combined effect 
of both drugs is equal to the sum of their independent effects when measured separately. 
Synergism is the situation in which the combined effect of both antibiotics is significantly 
greater than the sum of their independent effects when measured separately. 
Antagonism is defined as the interaction between antibiotics whereby the combined effect of 
both drugs is significantly less than the sum of their independant effect when measured 
separately.7 
Analysis of results. For statistical analysis of the results repeated measures analysis of variance 
was applied, after logarithmic transformation of the measured MBC values. Tests were 
performed at nominal significance level of 5%. In order to investigate a possible synergetic 
effect of the combination of the antimicrobials the MBC values of this combination were 
compared with the weighted means of the MBC values observed for each antimicrobial 
separately. 
RESULTS 
Nine hundred and twenty susceptibility tests were carried out on eighty strains (80 strains of 
Gram-negative bacilli) for polymyxin E, tobramycin and the mixture of these two agents in the 
presence of four different media. Two hundred eighty tests were done using polymyxin E and 
three hundred twenty for both tobramycin and the combination. 
Figures 2 and 3 depict the influence of the different media on the bactericidal activity of 
polymyxin E and tobramycin. Saliva, 50% saliva+ 50% TSB and TSB significantly reduced the 
killing action of tobramycin for all tested Gram-negative bacilli (p<0.01). Identical significant 
results were found for polymyxin E, except in the case of the Enterobacter and Klebsie/la 
species. Proteus species are intrinsic insensitive to polymyxin E. 
Figure 4 shows the influence of the four media on the bactericidal activity of the combination 
of polymyxin E and tobramycin against the eight different types of Gram-negative bacilli. Fresh 
whole saliva, 50% saliva + 50% TSB and TSB significantly reduced the cidal activity of the 
combination against the eight Gram-negative bacilli, when compared to glucose 5% (p<0.01). 
In all media addition was found for E.coli, Enterobacter and Klebsie/la species, whereas 
synergism was measured for Citrobacter, Proteus, Serratia, Pseudomonas and Acinetobacter 
species. Antagonism was not found. The range of the median MBC values of combined 
polymyxin E/tobramycin for all Gram-negative bacilli tested in fresh whole saliva were 2.1-9 .0 
mg/I and 1 .7-7.4 mg/I respectively. 
The control tests without the antimicrobial agents did not show any growth inhibiting effect 
of one of the four media on the 80 strains in our test system. 
DISCUSSION 
Chlorhexidine rinsing is found to be of limited value as oral flora elimination technique. 1•2 The 
high oral Gram-negative bacillary carrier state (more than half of the patients with head and neck 
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Figure 2: 
Median MBC values for polymyxin E in glucose 5%, fresh whole saliva, trypticase soya broth (fSB), and 
50% fresh whole saliva in TSB against 8 types of Gram-negative bacilli. Saliva , 50% saliva in 50% TSB, 
and TSB significantly reduced the cidal activity for all Gram-negative bacilli compared lo glucose 5%, 
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Figure 3: 
Median MBC values for tobramycin in glucose 5%, fresh whole saliva, trypticase soya broth (fSB), and 
50% fresh whole saliva in TSB against 8 types of Gram-negative bacilli. Saliva, 50% saliva in 50% TSB, 
and TSB significantly reduced the killing action of tobramycin for Gram-negative bacilli compared to 






E . co l i  K leb.sp Ent.sp C1tr .sp Prot.sp Serr.sp Pseud.sp Ac in .sp  
IZZl glucose 5% lS:SI saliva fZ2ZI TSB � 50% TSB + 50 % sal 
Figure 4: 
Median MBC values for the combination of polymyxin E and tobramycin (polymyxin E : tobramycin = 
5 : 4) in glucose 5%, fresh whole saliva. trypticase soya broth (fSB), and 50% fresh whole saliva in TSB 
against 8 types of Gram-negative bacilli. Saliva, TSB and 50% saliva in 50% TSB significantly reduced 
the cidal activity for all Gram-negative bacilli tested, when compared to glucose 5% (p<0.01).  
rinses. The inactivation experiments showed a significant reduction of the lethal activity of 
chlorhexidine for all Gram-negative bacilli tested in saliva when compared to glucose 5%. The 
range of the median MBC values of chlorhexidine for all Gram-negative bacilli tested in fresh 
whole saliva was between 20 and 62 mg/1.4 The use of lozenges with polymyxin E and 
tobramycin was associated with a complete eradication of Gram-negative bacilli from the 
oropharynx.3 This inactivation study showed that fresh whole saliva also significantly reduced 
the lethal activity of the antimicrobial combination against all Gram-negative bacilli tested 
when compared to glucose 5%. However, the range of the median MBC values of combined 
polymyxin E and tobramycin for all Gram-negative bacilli tested in fresh whole saliva was 2.1-
9.0 mg/I and 1 .7-7.4 mg/I respectively. These MBC values of polymyxin E and tobramycin 
being substantially lower than the MBC values of chlorhexidine for Gram-negative bacilli in the 
presence of saliva suggest a more pronounced influence of saliva on chlorhexidine. 
Besides inactivation by salivary proteins, the dose topically in the mouth is a second factor 
determining salivary concentrations lethal for Gram-negative bacilli colonizing the oropharynx. 
The lozenges used in the clinical study were calculated to release 2 mg of polymyxin E and 
1.8 mg of tobramycin in about 20 ml of saliva produced during the 15 minutes of intake (mean 
time that the patient needed to dissolve the lozenge in the mouth).8 These salivary concentrations 
achieved correspond with 100 mg/I of polymyxin E and with 90 mg/I of tobramycin, i.e. at least 
IO times the highestMBC's of the two antimicrobials for all isolates tested in saliva. These high 
lethal salivary concentrations guarantee an overkill to overcome person-to-person variations 
and may have contributed to the efficient eradication of oral Gram-negative bacillary carriage 
observed in the clinical study. 
9 1  
In the chlorhexidine rinsing study, the patient rinsed the mouth with 15 ml of 0.1 % 
chlorhexidine per oral washing. According to Bonesvoll et al. this theoretically resulted 
approximately in a salivary concentration of 300 mg/I of chlorhexidine, which is about five 
times the highest MBC's of chlorhexidine for all isolates tested in saliva.9 Whether this orally 
retained chlorhexidine concentration was still antimicrobiologically active was not detennined 
in that study. Apparently there are other conditions contributing to the outcome of oral flora 
elimination. 
Contact time between antimicrobial and micro-organism colozing the oropharyngeal mucosa 
has been suggested by Bodey.10 According to this author rinsing does not provide a proper 
contact between antibiotic and bacteria carried in the mouth. This suggestion is in line with a 
recent report on oral flora elimination in cardiac surgical patients. In that study oral instillation 
of 4 ml of a suspension containing 16 mg of polymyxin E (colistin) and 12 mg of tobramycin 
every six hours, was found not be effective as oral flora elimination technique.11  Otherwise, the 
use of a paste mixed with identical antibiotics has been reported to be extremely effective in 
prevention and treatment of Gram-negative bacillary carriage.12-15 It is very likely that the use 
of a lozenge with a sufficient concentration of chlorhexidine would have been associated with 
a successful elimination of Gram-negative bacilli from the oropharynx. But the chance is high 
that these topical chlorhexidine concentrations may be associated with severe side-effects 
including discoloration of the teeth, 16 interaction with indigenous flora 17 •18 and cell renewal.19 
The pharmaceutical technological application form seems to be important in oral flora 
elimination techniques. Lozenges and paste guarantee a longer and proper contact time between 
antimicrobial and bacterium colonizing the oral mucosa than mouth washes, oral instillation or 
gargling techniques do. 
It is evident that microbiological basics play an important role in selecting antimicrobials for 
oral flora elimination procedures.20•21 The spectrum of this mixture of polymyxin E and 
tobramycin covers all Enterobacteriaceae, Pseudomonadaceae and Acinetobacter species, 
while acquired resistance against polymyxin E is extremely rare.22.23 Polymyxins and amino­
glycosides which are surface-active (disinfecting) agents are bactericidal even against resting 
cells.22.7A-26 Both antimicrobials are non-absorbable providing constantly high intra-oral con­
centrations. Because of the absence of leucocytes in the oropharynx MBC' s are needed rather 
than minimal inhibiting concentrations (MIC's). Polymyxin E and tobramycin have both low 
MBC's for practically all Gram-negative bacilli, e.g. Pseudomonas species. Synergism is 
described between polymyxins and aminoglycosides.Z1-29 This study confirms these synergistic 
interactions for Citrobacter, Proteus, Serratia, Pseudomonas andAcinetobacter species in the 
presence of saliva. Synergism is thought to contribute to prevention of resistance in lowering 
MBC's. 
In summary, factors detennining the outcome of oral flora elimination procedures include 
spectrum, mode of action, pharmacokinetics, application fonn, salivary inactivation and doses. 
Fresh whole saliva has been found to reduce the bactericidal activity of polymyxin E and 
tobramycin, making increasing topical doses necessary for complete eradication of Gram­
negative bacillary carriage. 
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ABS1RACT 
Mucositis induced by irradiation is the reactive inflammatory-like process of the oropharyngeal 
mucous membranes following irradiation. Bacteria colonizing the oral tissues are thought to 
contribute to this process. The eradication of Gram-negative bacilli (selective elimination of oral 
flora) in fifteen comparably irradiated head and neck cancer patients was found to be associated 
with a significant reduction in mucositis compared with two groups of 15 patients receiving 
either placebo or chlorhexidine rinsing. Criteria used were the extent of local mucositis signs 
(mucositis score), as well as generalized side-effects such as the need of nasogastric tube 
feedings following severe feeding problems. Mucositis signs were confined to erythema only 
in all selectively decontaminated patients. No pseudomembranes were observed and artificial 
feeding was completely prevented. These promising results need further confirmation in larger 
(multicenter) studies. 
IN1RODUCTION 
Mucositis induced by irradiation is defined as the reactive inflammatory-like process of the 
oropharyngeal mucosa following irradiation in head and neck cancer patients.1 Radiation 
mucositis is a transient side-effect of therapeutic doses of irradiation. 
Mucositis is basically a tissue reaction. Baker2 described a sequence of histopathological 
effects: acute vascular response and oedema by the end of the first irradiation week (lOGy); after 
two weeks (approximately 20 Gy) the oedema may be more noticeable, resulting from the 
increased extra vascular fluid; cell death and mitotic inhibition together with continuing cell loss 
from the mucosa} surface will reduce the cellularity of the mucous membrane (week 3); in 
addition to the cytotoxic action of irradiation, the dose-fractions used in therapeutic programmes 
will increase the tissue permeability, more particularly after three weeks (30 Gy); the connective 
tissue becomes oedematous and the mucous membrane may be further stretched with local 
breakdown. 
At the end of the treatment (during the fourth and fifth week), the reaction of the mucous 
membrane is at a maximum. Four clinical signs of mucositis, namely white discoloration, 
erythema, pseudomembranes and ulcerations run parallel with these progressive radiobiologi­
cal changes in the oral mucous membranes.3 
Yeast stomatitis and generalized symptoms such as feeding problems may complicate further 
the irradiation course.4.5 
Oral hygiene programmes are commonly advised to prevent or reduce discomfort associated 
with irradiation mucositis. Mouth rinses are prescribed mainly for two reasons: (1) mechanical 
cleansing of the mouth to clear necrotic tissue and debris, and (2) to prevent yeast stomatitis. 
Bemhoft and Skaug6 suggest that chlorhexidine rinsing may prevent or reduce mucositis caused 
by irradiaton. The concept is as follows: antimicrobials would reduce mucositis via reduction 
of oral flora. The oral bacteria are thought to play a role in promoting or maintaining mucositis. 
Our group was not able to show any difference in mucositis, whereas the only flora 
suppression effect established by chlorhexidine was a significant reduction of the colonization 
index of the oral cavity for viridans streptococci.7 Chen et al. and Martin et al.4•8 showed that 
irradiation mucositis was not influenced by the absence or presence of yeast species. Our 
previous findings confinns this.7 Surprisingly the carrier state of Gram-negative bacilli was high 
in this population and was not affected by chlorhexidine rinsing at all in both studies.6•7Realizing 
that these micro-organisms continuously release endotoxin9•10 - a potent inflammation media-
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tor11  - we decided to undertake a study aiming at oral elimination of these Gram-negative bacilli 
from the oral cavity.12 
This prospective pilot study is undertaken to evaluate the effect of elimination of oral Gram­
negative bacilli on mucositis in irradiated head and neck cancer patients. The outcome will be 
compared with the results of our previous study on the effect of placebo and chlorhexidine 
rinsing on irradiation mucositis.7 
MA lERIALS and METHODS 
Scoring mucositis. Mucositis was evaluated using qualitative and quantitative parameters. Four 
different local signs of mucositis might be distinguished: 1 = white discoloration, the white 
appearance of oral mucosa; 2 = erythema, defined as redness more pronounced than the red 
colour of non-irradiated normal mucosa; 3 = formation of pseudomembranes, i.e. white or 
yellow mucous plaques which are difficult to detach; 4 = ulceration, defined as the local 
complete loss of the mucosal layer. Mucositis of the oral cavity was determined for maximally 
eight (n = 8) distinguishable irradiated areas of the mouth: buccal mucosa (left & right), soft and 
hard palate, dorsum and border of the tongue (left & right) and the mouth floor. An area (the 
i-th area; i = 1, ... n) might include several subareas dependent on the different local signs of 
mucositis observed in that particular area. The degree of mucositis for each subarea was scored 
by the value k on an ordinal scale (table I). In one particular area there might be several subareas 
Table 1 :  The indices for the local mucositis signs and the indices for the length of the mucositis signs as 
used in the mucositis score a. 
Local sign k Length E 
No mucositis 0 
White discoloration 1 S 1 cm 1 
Erythema 2 1-2 cm 2 
Pseudomcmbranes 3 2-4 cm 3 
Ulceration 4 > 4 cm  4 
with an identical local sign of mucositis. The length of each subarea was measured by a modified 
pocket gauge (gauge of 2 cm), which was handy to use in the oral cavity, more particular in the 
more inaccessible areas, e.g. the mouth floor. The lengths of all subareas of identical local sign 
in one particular area were summed. The lenght (sum oflenghts) of subareas corresponded with 
a value E on an ordinal scale (table 1). The degree of mucositis of a subarea was defined as the 
product of the values k and E. The mucositis score of an area was defined as the sum of these 
products. Finally, the mucositis score a was defined as the mean of the scores assigned to n 
irradiated areas; the formula of the mucositis score a is as follows: 
n 4 





The mucositis score a is a combination of ordinal scale assessments. The choice of the scores 
is subjective, inevitably. Despite the arbitrariness involved one might expect that a higher score 
a corresponded with a clinically more severe condition. 13 
Yeast stomatitis. This is defined as an acute infection of the mucous membranes of the oral 
cavity. The most common symptoms of yeast stomatitis are burning sensation, tenderness and 
dryness. Clinically yeast stomatitis may present itself as superficial strand-like or drop-like 
growths that become confluent and form pearly-white elevated patches that resemble milk 
curds; or as a deep red erosion of the oral mucosa and patchy depapillation of the dorsum of the 
tongue, with minimal evidence of white lesions.14 Yeast stomatitis is mostly associated with 
� 105 colony forming units of yeast cells per ml of saliva. 15 
Evaluation of generalized side effects. Local mucositis signs may be that severe that the 
patient may suffer pain in chewing, swallowing, speech and eating. These complaints may 
interfere with the feeding of the patient. Weight loss is an objective criterium and reflects best 
a real feeding problem. 16 The only criterium for generalized side effects used in this study was 
weight loss, leading to the need of nasogastric tube feedings, defined as a loss of more than 
1 kg per week. 
Patients. All patients participating in this study were obtained by informed consent. For all 
head and neck cancer patients in this study the irradiation procedures, i.e. field size of irradiation 
(volume), fractionation (2 Gy daily/five times weekly), irradiation source (linear accelerator 
4 MeV), techniques (bilateral radiation via parallel opposed portals), were identical up to a total 
midline dose of at least 50 Gy (5 weeks). The irradiated tissue volumes in all patients were such 
that the major salivary glands (parotid and submandibular) were included. Most of the patients 
were operated before irradiation, either by radical resection or debulking of the primary tumor. 
Dental examination and treatment in case of infectious foci or of mechanical irritation preceded 
the course of radiotherapy. Dentate patients applied daily a neutral fluoride gel in custom made 
trays, whereas edentulous patients were not allowed to wear their prostheses during the course 
of radiotherapy. 
Study design. Fifteen consecutive patients were studied prospectively. After receiving 
informed consent, all patients used lozenges of 1 gram containing an antimicrobial combination 
of polymyxin E (colistin) 2 mg, and tobramycin 1. 8 mg. To prevent clinical problems by yeast 
stomatitis amphotericin B 10 mg was added. The administration frequency was four times daily 
started on the first day of irradiation for the five consecutive weeks of irradiation course. 
In all patients the oral cavity was sprayed daily with a flavoured deionized water solution 
(without any inhibiting effect on bacteria) during the course of irradiation. Further the patients 
rinsed their mouths by themselves as well during 1 minute, three times a day. The amount of 
sprayed and rinsed fluid was about 100 ml per day (spraying with 50 ml and three times rinsing 
with 15 ml). 
Analysis of results. The results of this prospective pilot study were compared with a previous 
placebo controlled study of the effect of chlorhexidine 0.1 % rinsing on mucositis, recently 
performed in 30 patients by our group.' For comparison of the mucositis score in the study 




Fifteen patients entered the study. Table 2 shows the patients characteristics. 
Tables 3 and 4 show the clinical data of the fifteen patients during the five weeks of irradiation 
course. The first sign of mucositis was erythema in all patients and was seen within 10.1 days 
(s.d. 3.6) at an irradiation dose of 14.9 Gy (s.d. 4.9). Neither pseudomembranes nor ulcerations 
Table 2: Data of the 15 patients (4 female, 1 1  male) using lozenges containing polymyxin E, tobramycin 
and amphotericin B. Twelve patients underwent surgery before irradiation. 
patient age sex type neoplasm* surgery irrad. dose (Gy) 
31 52 f sec no 50 
32 37 m sec yes 66 
33 43 m sec yes 70 
34 72 m sec yes 70 
35 74 m sec yes 66 
36 48 m sec yes 66 
37 61 m sec yes 66 
38 51 f sec yes 70 
39 72 f sec no 66 
40 80 f sec yes 70 
41 57 m sec yes 70 
42 77 m sec yes 70 
43 46 m sec no 70 
44 83 m sec yes 66 
45 67 m sec yes 66 
mean f : m  yes : no 
61 .  3 4 :  1 1  1 2  : 3 
* sec= squamous cell carcinoma 
were observed in any patient, implying that erythema was the only local mucositis sign in this 
group receiving selective elimination of the oral flora. The highest mucositis score was 6.2 (s.d. 
1.5) due to extent and spreading of erythema. This score was obtained at day 21.7 (s.d. 5.7) at 
30 Gy (s.d. 7.8). Yeast stomatitis was completely prevented and the significant reduction in 
number of patients needing nasogastric tube feedings was impressive, none of the patients 
needed this type of feeding. 
Table 5 shows the results in the threeanns of the study concerning most severe mucositis sign, 
highest mucositis score, yeast stomatitis and weight loss for the fifteen patients using lozenges, 
and the two groups of fifteen patients rinsing with placebo or chlorhexidine. 
Figure I shows the mucositis score a in the three arms of the study: (1) mucositis score a pattern 
in 15 patients receiving placebo rinsing; (2) mucositis curve in 15 patients getting an oral 
hygiene programme based on chlorhexidine 0.1 % rinsing, and (3) the course of mucositis in 
fifteen patients during selective elimination of oral flora by lozenges containing polymyxin E, 
tobramycin and amphotericin B. The effect of the three oral hygiene regimens are characterized 
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Table 3: The signs of mucositis in the 15 patients using lozenges containing polymyxin E, tobramycin and 
amphotericin B. 
patient sign time (day) dosis (Gy) a 
31  Erythema 7 10 1.1 
32 Erythema 10 16 2.3 
33 Erythema 10 16 2.9 
34 Erythema 16 22 3.4 
35 Erythema 10 12 1 . 1  
36 Erythema 1 1  18 3.1 
37 Erythema 15 22 4.6 
38 Erythema 10 16 4.3 
39 Erythema 6 10 3.4 
40 Erythema 15 22 1 .7 
41 Erythema 14 18 2.3 
42 Erythema 7 10 0.9 
43 Erythema 7 10 0.9 
44 Erythema 10 16 2.3 
45 Erythema 3 6 1 .0 
Mean 10.l 14.9 2.4 
s.d. 3.6 4.9 1.2 
Table 4: Thehighestmucositis score and generalized symptoms in the patients using lozenges containing 
polymyxin E, tobramycin and amphotericin B. Nasogastric tube feedings and yeast stomatitis 
were completely prevented. 
patient sign time (day) dosis (Gy) a Symptoms 
31 Erythema 17 24 8.0 
32 Erythema 15 22 6.9 
33 Erythema 36 50 7.4 
34 Erythema 21 26 6.9 
35 Erythema 24 26 4.6 
36 Erythema 30 44 5.1 
37 Erythema 22 30 6.9 
38 Erythema 22 32 6.9 
39 Erythema 13 20 6.9 
40 Erythema 18 24 2.1 
41 Erythema 26 32 7.4 
42 Erythema 21 30 6.9 
43 Erythema 21 30 4.6 
44 Erythema 24 34 6.9 
45 Erythema 15 22 5.0 
Mean 21.7 30.0 6.2 
s.d. 5 .7 7.8 1 .5 
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Table 5: Most severe mucositis sign, mucositis score and generalized symptoms for the lozenge group, 
placebo rinsing group and chlorhexidine rinsing group. 
criteria placebo chlorhexidine polymyxin E/tobramycin/ 
rinsing amphotericin B lozenge 
a. most severe sign pseudomembrane pseudo membrane erythema 
of mucositis 18.8 (sd) 5.3 days 15.3 (sd) 2.7 days 10.1 (sd) 3.6 days 
26.7 (sd) 7.1 Gy 21.8 {sd) 2.9 Gy 14.9 {sd) 4.9 Gy 
b. highest score 9.3 (sd) 1.4 9.1 (sd) 3.5 6.2 (sd) 1 .5 
of mucositis (a) 28 (sd) 5.3 days 21.5 (sd) 5.1 days 21.7 (sd) 5.7 days 
38.5 (sd) 7.5 Gy 3 1 .6 (sd) 7 .9 Gy 30 (sd) 7.8 Gy 
c. yeast stomatitis two patients no patient no patient 
22 days/30 Gy 
36 days/50 Gy 
d. tube feeding five patients three patients no patient 
25 days/33.6 Gy 20 days/29 .3 Gy 
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Figure 1 :  
Mucositis score a in the three parts o f  the study. The mucositis score was significantly reduced after 3 
weeks of irradiation in the patients using lozenges (including polymyxin E, tobramycin and amphotericin 
B) compared to the placebo and chlorhexidine 0.1 % rinsing group (p<0.05). 
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by the typical S-curve. While no difference in mucositis was seen between placebo and 
chlorhexidine group, a significant mucositis score reduction was found after three weeks in the 
group with selective flora elimination. The complete absence of pseudomembranes and 
decreased extension of erythema may explain these findings. 
DISCUSSION 
The purpose of this study was to evaluate wether selective elimination of oral flora (i.e. Gram­
negative bacilli) reduced mucositis. The answer is positive, because the most severe sign of 
mucositis - pseudomembranes - was completely prevented and the mucositis score was signifi­
cantly reduced after three weeks of therapeutic irradiation. Moreover, generalized side effects 
monitored by weight loss and nasogastric tube feedings were completely prevented as well. 
The relationship between an oral cavity that was successfully decontaminated,19 i.e. free of 
Gram-negative bacilli (artificially restored to normal physiological conditions) and an oral 
cavity displaying erythema only during the five weeks of irradiation protocol is striking. The 
phase of erythema was not affected by the preventive measures suggesting that erythema is a 
pure irradiation induced tissue reaction characterized by a steep slope of the dose-response S­
curve. 20 In the other 30 patients of whom more than half of the total number were oral carriers 
of Gram-negative bacilli, the development of pseudomembranes occurred practically always at 
the end of the third irradiation week, while extension and spreading of this severe mucositis sign 
occurred in the last two weeks. These observations suggest that the oral carrier state of Gram­
negative bacilli at the end of the third week may be a crucial condition in the pattern of irradiation 
induced mucositis. 
The mediator between oral carriage of Gram-negative bacilli and mucositis may be en­
dotoxin, released by colonizing Gram-negative bacilli. The arguments supporting this working 
hypothesis are as follows: (1) endotoxins are potent inflammation inducers;11 (2) the low 
salivary concentration of Gram-negative bacilli (about 10 colony forming units per ml of saliva) 
which results from clearance by swallowing and chewing does not contradict a substantial 
salivary concentration of endotoxin;9 (3) the time of onset of the most severe sign of mucositis 
i.e. pseudomembranes and afterwards the extension and spreading of the lesions is in accordance 
with the time that increased permeability of oral mucous membranes is caused by a dose of 
30 Gy at day 21.2 Increased permeability may allow endotoxin to pass through, to induce the 
cascade of inflammation processes;21 ( 4) polymyxins, one of the components in the lozenge are 
shown to be effective endotoxin neutralizers both in vitro22 and in vivo.23 A patient who has 
head and neck cancer and who needs irradiation may benefit from an oral cavity free of 
endotoxin, more particulary at about the end of the third week, i.e. the period the patient is 
leaking through the permeable oral tissues. A study investigating the difference in salivary 
endotoxin content of placebo treated patients and successfully decontaminated patients is now 
in progress. 
Although it is unlikely that yeast colonization has anything to do with the pathogenesis of 
mucositis,4•8·1,4 preventive administration of topical antifungals is indicated in this population to 
prevent yeast stomatitis. The antifungal agents that were studied up to now in irradiated patients 
are chlorhexidine,6·1,4 amphotcricin B,4 natamycin and nystatin25 and ketoconazole.26 All 
antifungals were found to be useful in preventing stomatitis. Complete eradication of yeasts was 
found to be extremely difficult. The underlying mechanism of effective clinical control of yeast 
stomatitis is probably related to reduction of intrinsic pathogenicity, i.e. control of tissue 
adherence by these antifungals.27•28 
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The striking observation that no patient needed nasogastric tube feedings may reflect an 
effective prevention of mucositis signs in successfully decontaminated patients. Realizing that 
the number of patients studied was small and that the weakness in the design of the study was 
that it was a consecutive one. Larger studies with a concurrent design are needed therefore. 
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1 SIGNIFICANCE OF THE STUDY 
1.1  Aims of the study 
1. Is it possible to prevent irradiation mucositis via oral flora elimination? 
2. If it is true that flora plays a (partial) role in irradiation mucositis, what fraction of the oral 
flora may be involved? 
3. To evaluate oral Gram-negative bacillary carriage. 
4. Is it possible to eradicate Gram-negative bacilli from the oral cavity? 
5. To evaluate oral yeast carriage. 
6. Is it possible to eradicate yeasts from the oral cavity? 
7. To determine the pathogenesis of yeast stomatitis. 
8. To determine the 'selectivity' of elimination of oral flora. 
1.2 What is achieved and not achieved in attaining these aims? 
The clinical results of this study are summarized in table 1 .  
1 .  This study shows that successful elimination of  Gram-negative bacilli from the oral cavity 
was associated with complete prevention of pseudomembranes. The first signs of mucosi­
tis, i.e. white discoloration and erythema were not preventable. 
2. This study reveals a relationship between a high oral carriage of Gram-negative bacilli and 
the occurrence of pseudomembranes. An effective prevention of pseudomembranes was 
observed as soon as Gram-negative bacilli had been eradicated from the oral cavity. 
Viridans streptococci were significantly reduced in the presence of pseudomembranes, 
whereas Enterococcusfaecalis was significantly increased in the absence of pseudomem­
branes in this study. 
3. A high Gram-negative bacillary carriage was detected in the inventory study (> 50% ). Oral 
carriage of these bacilli, uncommon in healthy people, was considered as a symptom of 
impaired colonization defence associated with underlying disease and surgery. 
4. Chlorhexidine 0. 1 % rinsing failed in eradicating Gram-negative bacilli from the mouth, 
whilst the use of lozenges including polymyxin E/tobramycin was associated with a 
complete elimination of these micro-organisms after three weeks of application. Inactiva­
tion by saliva was shown to play a role in the outcome of elimination of oral flora. All 
antimicrobials tested were inactivated, but the range of the median MBC values of 
chlorhexidine for all Gram-negative bacilli in fresh whole saliva (20-62 mg/I) was higher 
than the range of the median MBC values of the antimicrobial mixture for Gram-negative 
bacilli in saliva (2-9 mg/I). 
5. Yeast carriage was within the nonnal values during the whole course of irradiation protocol 
(20-40%). 
6. Chlorhexidine 0.1 % rinsing failed in eradicating yeasts from the mouth, whilst the use of 
amphotericin B lozenges significantly reduced yeast carriage. 
7. Yeast stomatitis did not occur in the thirty patients using antifungals. Chlorhexidine 0.1 % 
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was not associated with a significant reduction of either carriage or concentration, whilst 
amphotericin B resulted in successful elimination of yeasts. 
8. The successful elimination of oral flora using lozenges containing polymyxin E, tobramy­
cin and amphotericin B was associated with a significant increase of both carriage and 
concentration of Ef aecalis. This shift was not observed during chlorhexidine treatment that 
significantly reduced viridans streptococci after five weeks. 
Table 1: The clinical results of this study 
criteria placebo chlorhexidine polymyxin E/tobramycin/ 
rinsing amphotericin B lozenge 
1 clinical 
a. most severe sign pseudomembrane pseudomembrane erythema 
of mucositis 18.8 (sd) 5.3 days 15.3 (sd) 2.7 days 10. 1 (sd) 3.6 days 
26.7 (sd) 7.1 Gy 21.8 (sd) 2.9 Gy 14.9 (sd) 4.9 Gy 
b. highest score 9.3 (sd) 1 .4 9.1 (sd) 3.5 6.2 (sd) 1 .5 
of mucositis (a) 28 (sd) 5.3 days 21.5 (sd) 5.1 days 21.7 (sd) 5 .7 days 
38.5 (sd) 7.5 Gy 31 .6 (sd) 7.9 Gy 30 (sd) 7.8 Gy 
c. yeast stomatitis two patients no patient no patient 
22 days/30 Gy 
36 days/SO Gy 
d. tube feeding five patients three patients no patient 
25 days/33.6 Gy 20 days/29 .3 Gy 
2 microbiological 
e. viridans no changes CI* sign. reduced no changes 
streptococci (week S) 
f. enterococci no changes no changes carriage/CI sign. 
increased (week 2) 
g. yeasts no changes no changes carriage/Cl sign. 
reduced (week 2) 
h. G-negative no changes no changes carriage/CI sign. 
bacilli reduced (week 2) 
* CI = colonization index 
1.3 Achievements put into the context of previous work 
1. Reduction of mucositis induced by irradiation. Published information on successful 
prevention of mucositis induced by irradiation is scarce. Bemhoft and Ferretti report that 
intensive oral hygiene programmes including chlorhexidine rinsing reduce irradiation 
mucositis.1•2 Most authors agree that mucositis during therapeutic irradiation protocol is 
basically a tissue reaction, and hence difficult to avoid.3•4The most important achievement 
of this study is that selective elimination of oral flora was associated with a complete 
prevention of pseudomembranes, one of the most severe mucositis signs. Moreover, none 
of the patients with a successful selective elimination of oral flora showed generalized 
symptoms related to mucositis, e.g. weight loss and nasogastric tube feedings. In this study 
chlorhexidine 0. 1 % rinsing was not found to prevent mucositis, whilst lozenges including 
a mixture of polymyxin E, tobramycin and amphotericin B were associated with an 
effective mucositis prophylaxis. Not all signs of mucositis were preventable. The first signs 
of mucositis of erythema were still present in all patients. 
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2. Pathogenesis of mucositis. The results of this study provide newer insights in the 
pathogenesis of irradiation mucositis. There are two approaches: (1) irradiation mucositis 
is a pure side effect of therapeutic irradiation and/or (2) oral flora is involved in the 
pathogenesis of irradiation mucositis. Yeasts are thought by some authors to be the most 
likely candidates.5 This study shows that eradication of Gram-negative bacilli was associ­
ated with a successful prevention of the severe signs of irradiation mucositis, while the first 
signs of white discoloration and erythema were not preventable. Those signs are apparently 
related to irradiation only. The recognition that a particular fraction of the oral flora, i.e. oral 
Gram-negative bacillary carriage, is involved in the severe mucositis signs (pseudomem­
branes) may be considered as innovative in tenns of published infonnation. 
3. Oral carriage of Gram-negative bacilli. Different groups report the emergence of Entero­
bacteriaceae, Pseudomonadaceae and Acinetobacter species colonizing the oral cavity of 
patients wo have head and neck cancer during therapeutic irradiation protocol.1•6•1 1 The 
significance of this phenomenon is not explained by these authors. This study confir,ns 
these observations. A high oral carriage rate (50-60%) of Gram-negative bacilli that 
persistently colonized this patient group was found in this thesis. This high percentage was 
found to be present before the onset of irradiation. Oropharyngeal carriage of the Gram­
negative bacilli is uncommon in healthy people because of intactness of the seven factors 
contributing to integrity of colonization defence of the oral cavity (chapter 1 and chapter 
3). Underlying disease is the most important factor interfering with the clearance of Gram­
negative bacilli of the oral cavity. Medical interventions such as surgery have been reported 
to promote the impairment of clearance. More than 80% of our patients (37 out of 45 
patients) underwent surgery before irradiation protocol. Fibronectin has been reported to 
cover oral mucous membranes preventing adherence and colonization.12 A correlation 
between decreased fibronectin after bypass surgery and higher oral carriage of Gram­
negative bacilli has been reported. Advanced age may be another factor promoting a high 
carrier state. The mean age of our study population was about 60 years. Although the seven 
factors contributing to intact colonization defence are impaired by irradiation, the carrier 
state of Gram-negative bacilli was not influenced by the therapeutic irradiation protocol in 
this study. No explanation for this observation has been found. 
4. Eradication of Gram-negative bacilli from the oral cavity. Rinsing with either placebo or 
chlorhexidine 0. 1 % did not result in a significant reduction of Gram-negative bacilli carried 
in the mouth. The complete absence of suppression or elimination of these micro-organisms 
during chlorhexidine rinsing has been recently reported by Bemhoft & Skaug and Ferretti 
et al.1 •13 There is no literature available describing successful elimination of Gram-negative 
bacilli from the oropharynx. Bodey14•15 and Kurrle16 reported that to achieve eradication of 
Gram-negative bacilli from the oropharynx is extremely difficult, probably because of the 
short contact time of the antimicrobials with the oral mucosa. Rinsing apparently does not 
guarantee a proper contact time. In this study was found that chlorhexidine is inactivated 
by saliva increasing the MBC's of chlorhexidine for Gram-negative bacilli. The combina­
tion of these two factors may explain the failures of elimination of Gram-negative bacilli 
from the oropharynx by chlorhexidine as observed in this study. Selective elimination of 
the Gram-negative bacilli was based on the use of lozenges containing a mixture of the 
antimicrobials polymyxin E and tobramycin. The mixture of those two agents (in a paste) 
was already described in the literature.11•19 The introduction of lozenges with this mixture 
for selective elimination purposes may be considered as 'novel '. The Gram-negative bacilli 
were successfully eliminated after three weeks in all patients. A lower inactivation rate by 
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saliva with higher concentrations of antimicrobials in the lozenges may explain the 
promising results. 
5. Oral yeast carriage. Several reports are available on yeast carriage in patients who have 
head and neck cancer. A carriage rate varying between 20-40% has been reported in patients 
who have head and neck cancer prior to therapeutic irradiation protocoJ.20•22 The results of 
the baseline study (chapter 3) with 21 % yeast carriage confirms these previous reports. 
These percentages do not differ from normal values.23·2,1 A non-significant increase of yeast 
carriage was observed in the placebo and chlorhexidine rinsing groups, and no increase of 
yeast concentration per ml of saliva was observed. This is not in line with other studies that 
report an increase in both carriage and concentrations.10•1 1 •20 The recognition of yeast 
carriage having a pathogenetic role in irradiation mucositis is still subject of debate in the 
Iiterature.5•1 0•20•22 Chen & Webster and Pau et al. did not see any correlation between yeasts 
and irradiation mucositis.20•22 
6. Elimination of yeasts from the oral cavity. The literature reveals that practically all 
antifungals are effective in preventing and treating yeast stomatitis.11 •25•26 The antifungals 
investigated in this study were chlorhexidine and amphotericin B. Although a complete 
eradication of yeasts was not observed with either of the antifungals, a significant reduction 
was achieved using amphotericin B compared to the placebo and chlorhexidine rinsing 
groups. This significant difference may be explained by the facts that amphotericin B is an 
intrinsically more potent antifungal than chlorhexidine (lower MBC values) and that 
amphotericin B was applied in lozenges guaranteeing a proper contact time. 
7. Pathogenesis of oral infections (stomatitis). Careful examination of the infections of the 
mouth in the 45 patients shows that stomatitis was caused by yeasts in two patients using 
placebo rinsing only. No yeast stomatitis was seen in the chlorhexidine and amphotericin 
B groups. Although the placebo rinsing patients carried viridans streptococci (100%) and 
Gram-negative bacilli (60%) in the oropharynx, none of the oral infections was associated 
with these micro-organisms. After three weeks of irradiation six out of fifteen patients 
(40%) carried yeasts in the oropharynx and two patients developed yeast stomatitis. 
Although the figures are small, these observations suggest that the intrinsic pathogenicity 
of yeasts is higher than that of viridans streptococci and Gram-negative bacilli in that type 
of patient. Many factors (e.g. adherence, production of toxins, micropili, slime production) 
are associated with intrinsic pathogenicity. A complete eradication of yeasts is well known 
to be difficult to achieve.25•27 Yeast stomatitis was successfully prevented in all thirty 
patients receiving chlorhexidine and amphotericin B, despite the lack of complete eradica­
tion. These observations suggest another pathogenic mechanism for oral infection by yeasts 
than growth density only, e.g. adherence to the mucosa. 2A Chlorhexidine might be effective 
in reducing the adherence of yeast species to mucosal cells.28 The high intrinsic pathogen­
icity of yeasts suggests the need of a prophylaxis with an antifungal agent in irradiated 
patients who have head and neck cancer. 
8. 'Selectivity' of elimination of oral flora. A shift of the oral flora towards Efaecalis was 
observed during the use of lozenges including polymyxin E, tobramycin and amphotericin 
B. This suggests a possible impact on the oral ecology. Chlorhexidine mouth rinses 
significantly reduced viridans streptococci. Recently Barthen showed an interaction 
between chlorhexidine rinsing and the indigenous anaerobic oral flora,29 chlorhexidine 
covers both aerobes and anaerobes. These preliminary results of selective flora elimination 
suggest an influence on the oral ecosystem. 
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2 HYPOTHESIS 
The individual who has head and neck cancer and who receives therapeutic irradiation after 
surgery is a typical patient at high risk of oral colonization with Gram-negative bacilli. All 
factors contributing to an effective clearance of these micro-organisms are impaired, and 
persistence of carriage has been considered as a symptom of being ill. The first signs of mucositis 
(white discoloration and erythema) occur in the first two weeks of conventional irradiation 
protocol. The severe sign of mucositis (pseudomembranes) as well as the highest mucositis 
score, and the generalized symptoms of weight loss and nasogastric tube feedings are observed 
at the end of the third week. This is the week in which the cancer patient receives 30 Gy, i.e. the 
dose associated with increased permeability of oral mucous membranes. 3 Gram-negative bacilli 
release endotoxin30 known to be a potent inflammation mediator.31 The working hypothesis is 
as follows: oral Gram-negative bacillary carriage may play a (direct or indirect via endotoxin 
release) role in the pathogenesis of mucositis, in particular of pseudomembranes. Selective 
elimination including polymyxin E may beresponsable for an effectiveendotoxin neutralization 
and hence for prevention of pseudomembrane formation.32 
3 SUGGESTIONS FOR FURTHER LINES OF RESEARCH 
The weak spots of this study are the small number of patients studied and the consecutive design 
of the selective elimination arm of the study. Confirmation of these results is required in a larger 
multicenter study with proper controls. 
Further work needs to be done into the underlying mechanisms contributing to the high oral 
Gram-negative bacillary carriage in the patients who have head and neck cancer. There may be 
a correlation between decreased fibronectin and the high carrier state. 
To elucidate the working hypothesis, salivary endotoxin should be evaluated in healthy 
people, in irradiated patients who develop pseudomembranes and who carry Gram-negative 
bacilli in the oropharynx, and in patients who are free from Gram-negative bacilli after 
successful elimination of these micro-organisms. 
To elucidate the role of yeasts in the irradiation mucositis, a study using amphotericin B 
lozenges without Gram-negative bacillary cover should be undertaken. 
Finally, a suggestion may be to initiate a clinical study in which the irradiation protocol is 
only started once the patient is free of Gram-negative bacilli. 
4 CONCLUSIONS 
1. The first signs of irradiation mucositis, i.e. white discoloration and erythema are tissue 
reactions associated with irradiation. Gram-negative bacilli contribute to the pathogenesis 
of the severe mucositis sign of pseudomembranes. 
2. Selective elimination of Gram-negative bacilli from the oral cavity prevents the formation 
of pseudomembranes, the highest mucositis score and generalized symptoms of weight loss 
and nasogastric tube feedings. 
3. Oral Gram-negative bacillary carriage is significantly higher in patients wo have head and 
neck cancer compared to healthy people. 
4. The use of lozenges including polymyxin E and tobramycin was associated with an 
effective elimination of Gram-negative bacilli from the oropharynx. Chlorhexidine 0.1 % 
rinsing was of limited value for these purposes. Chlorhexidine inactivation by saliva and 
the short contact time were found to be factors explaining these failures. 
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5. Oral yeast carriage did not differ from the carriage rate in healthy people. 
6. The lozenges including amphotericin B were found to be effective for elimination of yeasts 
from the oral cavity, whereas no significant difference was found during chlorhexidine 
0.1 % rinsing. 
7. Other pathogenic mechanisms than numbers of yeast cells contribute to oral infections by 
yeasts, e.g. adherence. 
8. Elimination of Gram-negative bacilli was associated with a shift in the oral flora towards 
the increase of Enterococcusfaecalis whilst chlorhexidine reduced viridans streptococci. 
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Summary 
Mucositis induced by irradiation is defined as the reactive inflammatory-like process of the oral 
mucous membranes following therapeutic irradiation in head and neck cancer patients. 
Clinically mucositis may be a serious side effect of therapeutic irradiation. Both severe local 
mucositis signs (pseudomembranes) and generalized symptoms (weight loss, feeding prob­
lems) may interfere with the well-being of the patient seriously and are therefore often dose-lim­
iting. 
Chapter 1 .  The introduction reviews the current knowledge about mucositis. Mucositis is 
thought to be basically a tissue reaction to irradiation. If oral micro-organisms are involved in 
mucositis, it is likely that their contribution is rather an aggravating than a causative one. The 
micro-organisms possibly involved are unknown. The factors contributing to colonization 
defence of the oropharynx are all impaired by irradiation. Individuals who have head and neck 
cancer and who receive therapeutic irradiation should be considered at high risk for colonization 
of Gram-negative bacilli. 
The aims of this study were: (1) to investigate whether elimination of oral flora reduces 
irradiation mucositis; (2) to study what part of the oral flora may be involved; (3) to evaluate oral 
Gram-negative bacillary carriage; (4) and to evaluate effective techniques for eradication; (5) 
to study oral yeast carriage; (6) and to study methods for complete elimination; (7) to gain better 
insights in the pathogenesis of oral infections by yeasts; (8) to determine 'selectivity' of oral 
flora elimination techniques. 
In chapter 2 a novel technique for scoring irradiation mucositis is described. This method is 
based on local signs of mucositis (qualitative and quantitiative) and does not include generalized 
clinical symptoms like the existing scoring methods do. The new method was compared to three 
other current methods: the WHO-, the Hickey-, and the Van der Schueren-method. Scoring 
mucositis in fifteen irradiated patients who have head and neck cancer displayed a S-curve, 
reflecting a symptomless first irradiation week, followed by a quick and steady increase of white 
discoloration, erythema and pseudomembranes during the second and third week for all scoring 
methods. The observations suggested that the third week (total dose of 30 Gy) is apparently a 
break point after which the more severe mucositis (pseudomembranes) and generalized 
symptoms emerge. 
In chapter 3 a new method is described for monitoring colonization defence by calculating 
the colonization index of the oral cavity. This index was evaluated as an indicator of ( decreased) 
colonization defence by comparing a group of healthy volunteers with a group of post-surgery 
patients with head and neck cancer. Oral colonization indices for Enterobacteriaceae, Pseudo­
monadaceae and Acinetobacter spp. as well as for Staphylococcus epidermidis were signifi­
cantly higher in the patient group compared to the volunteers. This study showed that the 
impaired colonization defence may be a result of the combination of underlying disease (cancer) 
and surgical intervention (debulking or radical resection of tumor) 
In chapter 4 the results of chlorhexidine 0.1 % mouth rinses on the oral flora were analysed. 
This prospective, randomized, placebo controlled, double blind study included 30 patients who 
have head and neck cancer and who were treated by conventional irradiation protocol. Only 
colonization indices of viridans streptococci were significantly reduced after five weeks of 
chlorhexidine 0.1 % treatment. The colonization patterns of Candida species, Enterococcus 
faecalis, staphylococci, Enterobacteriaceae, Pseudomonadaceae and Acinetobacter species 
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were not influenced by five weeks of use of chlorhexidine rinses compared to the placebo rinses. 
No differences were seen in the development and severity of mucositis between the two study 
groups. 
In chapter 5 the minimum bactericidal concentrations (MBC's) of chlorhexidine were 
studied for 120 isolates to explain the in vivo failures. MBC's were studied using a standard 
dilution m(..thod in fresh whole saliva, broth and glucose 5%. Both saliva and broth significantly 
reduced the bactericidal activity of chlorhexidine against all micro-organisms tested as 
compared to glucose 5% (p<0.01). The influence of saliva on the MBC's for indigenous flora 
(10-32 mg/I) were significantly lower than the values obtained for the 'hospital' acquired micro­
organisms (20-62 mg/I) (p<0.05). These observations of chlorhexidine inactivation by saliva 
may explain why chlorhexidine mouth rinsing is of limited value in decontaminating the oral 
cavity. The concentration of chlorhexidine rinses might be sufficient for the indigenous flora, 
but not for reduction or elimination of the 'hospital' acquired Gram-negative bacilli. 
In chapter 6 the effect of chlorhexidine 0. 1 % mouth rinses on irradiation mucositis is 
described. Fifteen patients received an oral hygiene protocol with chlorhexidine 0 . 1  % . The other 
fifteen patients were treated with a placebo solution. No differences were found between both 
groups. Twelve patients developed pseudomembranes in each group after a mean of 18.8 days 
(s.d. 5.3) in the placebo rinse group and 15.3 days (s.d. 2.7) in the chlorhexidine rinse group. 
Ulcerations were not observed in any study group. The highest mucositis score was 9 .3 (s.d. 1.4) 
and 9.1 (s.d. 3.5) respectively. Mycologically proven yeast stomatitis of the mouth was seen in 
two control patients only. The findings of this study supports the hypothesis that mucositis is 
primarily a tissue reaction due to radiation. However, the role of the oral flora could not be 
evaluated because of the inadequate effect of chlorhexidine rinsing (chapter 4). 
In chapter 7 the results are described of selective elimination of oral flora in fifteen irradiated 
patients with head and neck cancer who used lozenges containing 2 mg polymyxin E, 1.8 mg 
tobramycin and IO mg amphotericin B, four times daily. The results were compared with the 
findings of the previous study as described in chapter 4 (placebo and chlorhexidine mouth 
rinses). Eradication of the Gram-negative bacilli was achieved after three weeks in all patients. 
A significant increase of E.faeca/is was observed. Yeast stomatitis was prevented in the two 
groups using lozenges (including amphotericin B) and chlorhexidine mouth rinses. Mucositis 
was significant reduced in the patients using lozenges compared with the two groups of patients 
using placebo and chlorhexidine rinses after three weeks of therapeutic irradiation. The 
complete eradication of Gram-negative bacilli was associated with an effective prevention of 
pseudomembranes. Gram-negative bacilli are thought to contribute to that severe sign of 
mucositis in a direct or indirect (i.e. endotoxin release) way. The prevention of yeast stomatitis 
was not dependent on a complete elimination of yeasts only, suggesting another pathogenic 
mechanism, e.g. adherence, than numbers of yeast cells. 
In chapter 8 the results are evaluated of the influence of saliva on the MBC' s of tobramycin, 
polymyxin E ( colistin) and their combination for 80 Gram-negative bacilli of 8 different species. 
The bactericidal action of tobramycin was significantly reduced by saliva and broth for all 
isolates as compared to glucose 5%. Identical results were found for polymyxin E for all but 
Enterobacter and Klebsiella species. Both saliva and broth had a significant reducing impact on 
the cidal action of the combination of polymyxin E and tobramycin for all isolates. The range 
of the median MBC values of combined polymyxin E/tobramycin for all Gram-negative bacilli 
tested in fresh whole saliva was 1. 7-9 .0 mg/I. The antimicrobial concentrations achieved by the 
use of the lozenges (2.0 mg/g of polymyxin E and 1.8 mg/g of tobramycin) are at least ten times 
higher than the salivary MBC' s for all isolates tested. These results might explain the successful 
outcome of selective flora elimination. 
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In chapter 9 the effect of selective elimination of oral Gram-negative bacilli on irradiation 
mucositis is analysed. Fifteen irradiated patients using lozenges containing polymyxin E, 
tobramycin and amphotericin B were compared with 30 patients rinsing with placebo and 
chlorhexidine (chapter 6). The selective oral elimination was found to be associated with a 
significant mucositis reduction compared with two groups receiving either placebo or 
chlorhexidine rinsing. Mucositis was confined to erythema only in all patients free of Gram­
negative bacilli whereas in the two rinsing groups 80% of the patients developed pseudomem­
branes. Artificial feeding was completely prevented in the patients using lozenges, whilst 27% 
of the patients using rinses needed nasogastric tube feedings. 
Conclusions: 
1. The first signs of irradiation mucositis, i.e. white discoloration and erythema are thought to 
be pure tissue reactions associated with irradiation. 
2. Gram-negative bacilli contribute to the development of the severe mucositis sign of 
pseudomembranes. White discoloration and erythema were not found to be preventable. 
3. A high Gram-negative bacillary carriage (>50%) was found in patients who have head and 
neck cancer. 
4. Lozenges including polymyxin E and tobramycin were effective in eradicating Gram­
negative bacilli, whilst chlorhexidine 0.1 % mouth rinses were not successful. Salivary inac­
tivation is found to be one of the factors determining the outcome of oral flora elimination. 
5. Oral yeast carriage was within the normal values during the irradiation protocol. 
6. Although a significant reduction of yeasts was only achieved by amphotericin B lozenges; 
oral infections by yeasts were prevented by both chlorhexidine and amphotericin B. 
7. This observation suggests another pathogenic mechanism such as adherence than number of 
yeast cells only. 
8. The selective elimination of oral flora was associated with a shift towards Enterococcus 
faecalis, whilst chlorhexidine significantly reduced viridans streptococci. 
If the promising results of mucositis reduction by selective elimination of Gram-negative bacilli 
are confirmed by larger multicenter studies with proper controls, it may well prove to be a major 




Mucositis is een heftige, ontslekingsachtige reactie van het mondslijmvlies die optreedt als 
neveneffect van bestralingsbehandeling van patienlen met een maligne afwijking in het hoofd­
halsgebied. Klinisch kan mucositis een emstige belasting van de patient betekenen. Zowel 
emstige lokale symptomen (pseudomembranen) als algemene verschijnselen (gewichtsverlies, 
voedingsproblemen) kunnen hel welzijn van de patient in emstige mate negatief bemvloeden 
en zelfs noodgedwongen leiden tot een ongewensle reductie van de totale bestralingsdosis. Het 
zou een weldaad voor deze patienten zijn als mucositis zou kunnen worden voorkomen. Een 
belangrijk probleem hierbij is dat het niet bekend is of de mucositis zoals die zich bij patienten 
manifesteert een direct gevolg is van de bestraling of van bacterien die door verminderde 
kolonisatie-afweer een rol kunnen spelen. Het antwoord op deze vraag is van essentieel belang 
voor het ontwikkelen van mogelijkheden om de mucositis le reduceren. Om dit doel te bereiken 
was het nodig een mucositisscore te ontwikkelen leneinde een objectieve evaluatie mogelijk te 
maken. Verder was het nodig een inzicht te krijgen in de micro-organismen die een rol zouden 
kunnen spelen bij mucositis en tenslotte moest een doelgerichle methode worden ontwikkeld 
om het normale biologische evenwicht in de mond te herslellen. In klinische termen gesproken: 
het doe! van het onderzoek is een heftige ontsteking van het mondslijmvlies tijdens de bestraling 
le voorkomen zodat de patient geen pijn heeft en niel kunstmatig gevoed hoeft le worden. 
Hoofdstuk 1. Het eerste hoofdstuk geeft een overzicht van de kennis van mucositis ten tijde 
van het begin van ons onderzoek. Mucositis zou in wezen een weefselreactie op bestraling zijn. 
Als de orale flora al betrokken zou zijn bij mucositis werd aangenomen dat de bijdrage hiervan 
eerder een verergerende dan een etiologische factor zou zijn. Onbekend was welke micro­
organismen mogelijk een rol zouden spelen. Normaal bestaat er in de mond een biologisch 
evenwicht dat in stand wordt gehouden door de zgn. kolonisatie-afweer. De factoren die 
bijdragen in de kolonisatie-afweer van de mondholle (bijv. slikken, speekselsecretie) zouden 
alle worden aangetast door de bestraling. Dit maakt dat deze patienlen een groot risico lopen 
voor kolonisatie van Gram-negatieve bacterien in de mond-keelholte. 
De doelstellingen van ons onderzoek waren: (1) na te gaan in welke mate bestralingsmucosi­
tis wordt verminderd door eliminatie van orale flora; (2) te bepalen welk deel van de orale flora 
een rol speelt in de ontwikkeling van mucositis; (3) bepalen van het dragerschap van Gram­
negatieve bacterien en ( 4) het vinden van effectieve methoden voor volledige eliminatie; (5) het 
bepalen van het dragerschap van gisten in de mond; en (6) methoden te ontwikkelen voor 
volledige eliminatie; (7) een beler inzicht te krijgen in de pathogenese van schimmelinfecties 
in de mond; (8) de 'selectivileit' van methoden voor eliminatie van orale flora le bepalen. 
In hoofdstuk 2 wordt een nieuwe methode voor het scoren van bestralingsmucositis 
beschreven. Deze nieuwe methode maakt het mogelijk het voorkomen van mucositis objectief 
te meten. De methode is alleen gebaseerd op lokale mucositisverschijnselen (kwalitatief zowel 
als kwantitatiet) en niet bovendien op algemene symptomen, zoals dit het geval is bij de reeds 
bestaande methoden. De nieuwe wijze van documenteren is vergeleken met drie andere 
gangbare methoden: de WHO-, de Hickey- en de Van der Schueren-methode. Het scoren van 
ontwikkeling en verloop van mucositis bij vijftien bestralingspatienten met een maligne afwij­
king in het hoofd-halsgebied laat een S-vormige curve zien. De aandoening begint met een 
symptoomloze eerste bestralingsweek, gevolgd door een snelle en gelijkmatige toeneming in de 
tweede en derde week bij alle scoringsmethoden (witle verkleuring, erytheem, pseudomembra-
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nen). Deze bevindingen doen vennoeden dat vooral de derde bestralingsweek (totale dosis 
30 Gy) een keerpunt is waama emstiger mucositisverschijnselen (pseudomembranen) en alge­
mene symptomen optreden. 
In hoof dstuk 3 wordt een nieuwe methode beschreven om de kolonisatie-afweer te bepalen. 
Dit is mogelijk door het berekenen van de kolonisatie-index. Deze index vonnt een indicator 
voor (verminderde) kolonisatie-afweer en berust op vergelijking van een groep gezonde 
vrijwilligers met een groep post-operatieve patienten met tumoren in het hoofd-halsgebied. 
Orate kolonisatie-indices voor zowel Enterobacteriaceae, Pseudomonadaceae en 
Acinetobacter soorten als voor Staphylococcus epidermidis, waren, vergeleken met de situatie 
bij vrijwilligers, duidelijk hoger in de patientengroep. Dit onderzoek laat zien dat de vermin­
derde kolonisatie-afweer een gevolg zou kunnen zijn van een combinatie van onderliggend 
lijden (kanker) en operatief ingrijpen. 
Hoofdstuk 4. In de tandheelkunde en met name in de parodontologie wordt chloorhexidine 
0, 1 of 0,2% als bet meest werkzame orale desinfectans beschouwd. Het leek daarom van belang 
de waarde van dit middel ook bij de behandeling van mucositis te onderzoeken. Hierbij werd 
de invloed van chloorhexidine 0,1 % mondspoelingen op de orale flora geanalyseerd. Deze 
prospectieve, gerandomiseerde, placebo-gecontroleerde, dubbel blinde studie omvat dertig 
patienten met een maligne afwijking in het hoofd-halsgebied die behandeld warden met 
conventionele bestralingstherapie. Na vijf weken behandeling met chloorhexidine 0, 1 % waren 
alleen de kolonisatie-indices van vergroenende streptokokken significant afgenomen. De 
kolonisatiepatronen van Candida, Efaecalis, staphylokokken, Enterobacteriaceae, Pseudo­
monadaceae en Acinetobacter soorten waren niet be'invloed door deze mondspoelingen, 
vergeleken met een placebo. Er waren geen verschillen tussen de twee studiegroepen wat betreft 
ontwikkeling en emst van de mucositis waar te nemen. 
In Hoofdstuk5 wordthet onderzoek naarde minimale bactericide concentraties (MBC's) van 
chloorhexidine beschreven voor 120 verschillende bacterien, teneinde het verschil in resultaten 
tussen in vivo en in vitro situaties duidelijk te maken. Bij de MBC-bepalingen werd een 
standaard verdunningsmethode gebruikt in vers speeksel, bouillon en glucose 5%. In ver­
gelijking met glucose reduceerden zowel speeksel als bouillon de bactericide activiteit van 
chloorhexidine aanzienlijk (p<0.01). De invloed van speeksel op de MBC's van lichaamseigen 
flora (10-32 mg/I) was beduidend lager dan de waarden die verkregen werden voor Gram­
negatieve bacillen (20-62 mg/I) (p<0.05). Deze inactivatie van chloorhexidine door speeksel 
geeft een verklaring voor het geringe effect van chloorhexidine mondspoelingen bij de 
decontaminatie van de mondholte. De concentratie van de chloorhexidine mondspoeling mag 
clan voldoende zijn voor de lichaamseigen bacterien ( vergroenende streptokokken), ze is dat niet 
voor de reductie of eliminatie van Gram-negatieve bacterien. 
In hoofdstuk 6 wordt het effect van chloorhexidine 0, 1 % mondspoelingen op bestralingsmu­
cositis beschreven. Vijftien patienten kregen een mondhygieneprotocol met chloorhexidine 
0, 1 %. Vijftien andere patienten werden behandeld met een placebo-oplossing. Er werden geen 
verschillen in m ucositisscore tussen beide groepen gevonden. Twaalf patienten in iedere groep 
ontwikkelden pseudomembranen. In de groep die spoelde met placebo was dit na gemiddeld 
18,8 dagen (s.d. 5,3) en in de groep die spoelde met chloorhexidine na gemiddeld 15,3 dagen 
(s.d. 2,7). In geen van de studiegroepen kwamen ulceraties voor. De hoogste mucositisscore was 
9,3 (s.d. 1,4) in de placebo-groep en 9,1 (s.d. 3,5) in de chloorhexidine-groep. Mycologisch 
onderzoek wees uit dat slechts bij twee patienten in de controlegroep stomatitis voorkwam 
veroorzaakt door gisten. De resultaten van deze studie lijken de stelling te onderschrijven dat 
mucositis in de eerste plaats een weefselreactie is die veroorzaakt wordt door bestraling. Hierbij 
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moet warden aangetekend dat de rol van de orale flora niet kon warden geevalueerd door bet 
ontoereikende effect van mondspoelingen met chloorhexidine (hoofdstuk 4). 
Hoofdstuk 7. Met bet opmerkelijke resultaat van de studie m.b.t chloorhexidine ontstond het 
probleem hoe de rol van de Gram-negativen bij het ontstaan van mucositis dan wel kon warden 
onderzocht. Naar analogie van de orale selectieve decontaminatie bij intensive care patienten 
werd nu een studie opgezet. In aanmerking zouden moeten komen niet-resorbeerbare, lokaal 
wcrkende antibiotica met een selectieve werking tegen Gram-negatieve bacterien en gisten. In 
dit hoofdstuk warden de resultaten beschreven van selectieve eliminatie van orale flora bij 
vijftien bestralingspatienten met een maligne afwijking in bet hoof d-halsgebied die vier keerper 
dag zuigtabletten gebruikten, die 2 mg polymyxine E, 1 ,8 mg tobramycine en 10 mg amphoter­
icine B bevatten. De resultaten warden vergeleken met de bevindingen uitde voorgaande studie, 
zoals beschreven in hoofdstuk 4 (placebo en chloorhexidine mondspoelingen). Volledige 
eliminatie van de Gram-negatieve bacterien was na drie weken bij alle patienten bereikt. Er werd 
ecn aanzienlijke toeneming in dekolonisatie vanEfaecalis gezien. Stomatitis veroorzaakt door 
gisten werd voorkomen in zowel de groep patienten die zuigtabletten (met amphotericine B) 
gebruikte, als in de groep die spoelde met chloorhexidine 0, I %. Na drie weken bestralings­
therapie was de mucositis duidelijk minder bij de groep patienten die zuigtabletten gebruikte, 
vergcleken met de beide andere groepen patienten (placebo en chloorhexidine mondspoelin­
gen). De volledige eliminatie van Gram-negatieve bacterien had een effectieve preventie van 
pseudomembranen tot gevolg. Aangenomen wordt dat Gram-negatieve bacterien, direct of 
indirect, bijvoorbeeld door bet vrijkomen van endotoxinen, bijdragen tot de emstige mucosi­
tisverschijnselen. Het voork6men van stoma ti tis door gisten hoeft niet alleen afhankelijk te zijn 
van de mogelijkheid tot volledige eliminatie van gisten, maar kan ook warden bereikt door 
preventie van een ander pathogeen mechanisme zoals adhesie. Ook bet aantal gistcellen schijnt 
een rol te spelen. 
Hoofdstuk 8. Bij de lokale toepassing van antibacteriele middelen in de mond is bet van 
belang het effect van speeksel op de werkzaamheid van deze middelen te weten. In dit hoofdstuk 
wordt daarom de invloed geevalueerd van speeksel op de MBC's van tobramycine, polymyxine 
E (colistine) en een combinatie daarvan bij 80 Gram-negatieve bacterien van 8 verschillende 
soorten. De bactericide werking van tobramycine tegen alle bacterien was beduidend 
afgenomen in speeksel en bouillon, vergeleken met glucose 5%. Identieke resultaten werden 
verkregen bij polymyxine E ,  behalve voor de Enterobacter en Klebsiella species. Zowel 
spceksel als bouillon had een duidelijk beperkende invloed op de bactericide werking van de 
combinatie van polymyxine E en tobramycine voor alle bacteriesoorten. De reeks van MBC­
waarden voor de combinatie polymyxine E en tobramycine bij alle Gram-negatieve bacterien 
getest in vers speeksel bedroeg 1 ,  7-9 ,0 mg/I. De antibacteriele concentraties in de zuigtabletten 
(2,0 mg/g polymyxine E en 1 ,8 mg/g tobramycine) tijdens het gebruik zijn tenminste 10 keer 
hoger dan de MBC's voor speeksel bij alle geteste bacterien. Deze gegevens zouden de goede 
resultaten van selectieve flora eleminatie kunnen verklaren. 
In hoofdstuk 9 wordt het effect van selectieve eliminatie van Gram-negatieve bacterien in de 
mond op bestralingsmucositis geanalyseerd. Vijftien bestralingspatienten, die zuigtabletten 
met polymyxine E, tobramycine en amphotericine B gebruikten, werden vergeleken met de 
dertig patienten die of placebo of chloorhexidine mondspoelingen gebruikten (hoofdstuk 6). Bij 
vergelijking met de twee laatstgenoemde groepen bleek dat selectieve orale decontaminatie kan 
warden geassocieerd met een belangrijke vennindering van mucositis. Bij alle gedeconta­
mineerde patienten bleef de mucositis slechts beperkt tot erytheem terwijl zich in de beide 
andere groepen bij 80% van de patienten pseudomembranen ontwikkelden. In de groep die zuig-
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tabletten gebruikte was kunstmatige voeding niet meer nodig, terwijl in de andere groepen bij 
27% van de patienten neusmaagsonde-voeding nodig was. 
Conclusies: 
1. De eerste mucositisverschijnselen (witte verkleuring en erytheem) zijn zuivere weefselreac­
ties veroorzaakt door bestraling. 
2. Gram-negatieve bacterien dragen bij tot de ontwikkeling van emstige mucositisverschijnse­
len die gepaard gaan met pseudomembranen. Witte verkleuring en erytheem konden niet 
worden voorkomen. 
3. Patienten met een maligne afwijking in het hoofd-halsgebied hebben een hoog dragerschap 
(>50%) van Gram-negatieve bacterien. 
4. Voor de volledige eliminatie van Gram-negatieve bacterien zijn zuigtabletten met poly­
myxine E en tobramycine effectief gebleken, terwijl chloorhexidine 0, 1 % mondspoelingen 
geen resultaat hadden. 
5. Het voorkomen van gisten in de mond bleef binnen de normale waarden tijdens de 
bestralingstherapie. 
6. Ofschoon een duidelijke reductie van gisten alleen bereikt werd met zuigtabletten met 
amphotericine B, werden orale schimmelinfecties zowel door chloorhexidine als door 
amphotericine B voorkomen. 
7. Deze bevinding suggereert dat een ander oorzakelijk mechanisme een rol speelt dan alleen 
het aantal gistcellen, zoals vermoedelijk de adhesie van gistcellen. 
8. De selectieve eliminatie van de orale flora bleek een toeneming van Efaecalis te geven 
terwijl chloorhexidine de vergroenende streptokokken belangrijk verminderde. 
Wanneer de veelbelovende resultaten van mucositisvermindering door selectieve eliminatie 
van Gram-negatieve bacterien worden bevestigd door grotere studies in meerdere centra waar 
goede en nauwkeurige controles plaatsvinden, zal dat een belangrijke verbetering betekenen in 
de verzorging van de bestralingspatient met een maligne afwijking in het hoofd-halsgebied. De 
patient zal aanzienlijk minder pijn hebben in zijn mond, de mondhygiene zal verbeteren en de 
patient zal niet meer via de neus-maagsonde gevoed hoeven te worden. 
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The clinical investigations were performed at the Department of Oral and Maxillofacial Surgery (head: 
Prof. Dr. G. Boering), Department of Surgery/Oncology (head: Prof. Dr. J. Oldhoff), Department of 
Radiotherapy (head: Prof. Dr. J. Verrneij) of the University Hospital Groningen. The laboratory work was 
carried out at the Department of Oral Microbiology (head: Dr. A.H. Weerkarnp), of the University of 
Groningen and the Department of Medical Microbiology (head: Prof. Dr. C.A. Hart) of the University of 
Liverpool (U.K.). 
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